<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Dis Model Mech</journal-id>
<journal-id journal-id-type="iso-abbrev">Dis Model Mech</journal-id>
<journal-id journal-id-type="publisher-id">DMM</journal-id>
<journal-id journal-id-type="hwp">dmm</journal-id>
<journal-title-group>
<journal-title>Disease Models &amp; Mechanisms</journal-title>
</journal-title-group>
<issn pub-type="ppub">1754-8403</issn>
<issn pub-type="epub">1754-8411</issn>
<publisher>
<publisher-name>The Company of Biologists Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26769798</article-id>
<article-id pub-id-type="pmc">4852506</article-id>
<article-id pub-id-type="doi">10.1242/dmm.023903</article-id>
<article-id pub-id-type="publisher-id">DMM023903</article-id>
<article-categories>
<subj-group subj-group-type="hwp-journal-coll">
<subject>303</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>5-HT<sub>2A</sub> and 5-HT<sub>2C</sub> receptors as hypothalamic targets of developmental programming in male rats</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Martin-Gronert</surname>
<given-names>Malgorzata S.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="author-notes" rid="AN2">‡</xref>
<xref ref-type="corresp" rid="cor1">§</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stocker</surname>
<given-names>Claire J.</given-names>
</name>
<xref ref-type="aff" rid="af2">2</xref>
<xref ref-type="author-notes" rid="AN1">‡</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wargent</surname>
<given-names>Edward T.</given-names>
</name>
<xref ref-type="aff" rid="af2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cripps</surname>
<given-names>Roselle L.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Garfield</surname>
<given-names>Alastair S.</given-names>
</name>
<xref ref-type="aff" rid="af3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jovanovic</surname>
<given-names>Zorica</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>D'Agostino</surname>
<given-names>Giuseppe</given-names>
</name>
<xref ref-type="aff" rid="af3">3</xref>
<xref ref-type="author-notes" rid="AN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yeo</surname>
<given-names>Giles S. H.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cawthorne</surname>
<given-names>Michael A.</given-names>
</name>
<xref ref-type="aff" rid="af2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Arch</surname>
<given-names>Jonathan R. S.</given-names>
</name>
<xref ref-type="aff" rid="af2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Heisler</surname>
<given-names>Lora K.</given-names>
</name>
<xref ref-type="aff" rid="af3">3</xref>
<xref ref-type="author-notes" rid="AN2">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ozanne</surname>
<given-names>Susan E.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
</contrib-group>
<aff id="af1"><label>1</label><institution>University of Cambridge</institution>, <addr-line>Metabolic Research Laboratories and MRC Metabolic Diseases Unit</addr-line>, <institution>Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital</institution>, <addr-line>Cambridge CB2 0QQ</addr-line>, <country>UK</country></aff>
<aff id="af2"><label>2</label><institution>Clore Laboratory, Buckingham Institute for Translational Medicine, University of Buckingham</institution>, <addr-line>Hunter Street, Buckingham MK18 1EG</addr-line>, <country>UK</country></aff>
<aff id="af3"><label>3</label><addr-line>Department of Pharmacology</addr-line>, <institution>University of Cambridge</institution>, <addr-line>Cambridge CB2 1PD</addr-line>, <country>UK</country></aff>
<author-notes>
<fn fn-type="present-address" id="AN1">
<label>*</label>
<p>Present address: Rowett Institute of Nutrition and Health, University of Aberdeen, Greenburn Road, Bucksburn, Aberdeen AB21 9SB, UK.</p>
</fn>
<fn fn-type="equal" id="AN2">
<label>‡</label>
<p>These authors contributed equally to this work</p>
</fn>
<corresp id="cor1"><label>§</label>Author for correspondence (<email>msm32@cam.ac.uk</email>)</corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>1</day>
<month>4</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>4</month>
<year>2016</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="ppub"/>. -->
<volume>9</volume>
<issue>4</issue>
<fpage>401</fpage>
<lpage>412</lpage>
<history>
<date date-type="received">
<day>28</day>
<month>10</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>7</day>
<month>1</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© 2016. Published by The Company of Biologists Ltd</copyright-statement>
<copyright-year>2016</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0">
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<uri xlink:href="http://creativecommons.org/licenses/by/3.0">http://creativecommons.org/licenses/by/3.0</uri>), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="dmm-9-023903.pdf"></self-uri>
<abstract>
<title>ABSTRACT</title>
<p>Although obesity is a global epidemic, the physiological mechanisms involved are not well understood. Recent advances reveal that susceptibility to obesity can be programmed by maternal and neonatal nutrition. Specifically, a maternal low-protein diet during pregnancy causes decreased intrauterine growth, rapid postnatal catch-up growth and an increased risk for diet-induced obesity. Given that the synthesis of the neurotransmitter 5-hydroxytryptamine (5-HT) is nutritionally regulated and 5-HT is a trophic factor, we hypothesised that maternal diet influences fetal 5-HT exposure, which then influences development of the central appetite network and the subsequent efficacy of 5-HT to control energy balance in later life. Consistent with our hypothesis, pregnant rats fed a low-protein diet exhibited elevated serum levels of 5-HT, which was also evident in the placenta and fetal brains at embryonic day 16.5. This increase was associated with reduced levels of 5-HT<sub>2C</sub>R, the primary 5-HT receptor influencing appetite, in the fetal, neonatal and adult hypothalamus. As expected, a reduction of 5-HT<sub>2C</sub>R was associated with impaired sensitivity to 5-HT-mediated appetite suppression in adulthood. 5-HT primarily achieves effects on appetite by 5-HT<sub>2C</sub>R stimulation of pro-opiomelanocortin (POMC) peptides within the arcuate nucleus of the hypothalamus (ARC). We show that 5-HT<sub>2A</sub>Rs are also anatomically positioned to influence the activity of ARC POMC neurons and that mRNA encoding 5-HT<sub>2A</sub>R is increased in the hypothalamus of <italic>in utero</italic> growth-restricted offspring that underwent rapid postnatal catch-up growth. Furthermore, these animals at 3 months of age are more sensitive to appetite suppression induced by 5-HT<sub>2A</sub>R agonists. These findings not only reveal a 5-HT-mediated mechanism underlying the programming of susceptibility to obesity, but also provide a promising means to correct it, by treatment with a 5-HT<sub>2A</sub>R agonist.</p>
</abstract>
<abstract abstract-type="precis">
<p><bold>Summary:</bold> Maternal protein restriction increases fetal brain 5-HT and might contribute to changes in production and function of hypothalamic 5-HT<sub>2C</sub> and 5-HT<sub>2A</sub> receptors in the offspring later in life.</p>
</abstract>
<kwd-group>
<title>KEY WORDS</title>
<kwd>Serotonin</kwd>
<kwd>Developmental programming</kwd>
<kwd>Hypothalamus</kwd>
<kwd>Low birth weight</kwd>
<kwd>Maternal diet</kwd>
<kwd>Protein restriction</kwd>
</kwd-group>
<funding-group specific-use="FundRef">
<award-group>
<funding-source>
<institution-wrap>
<institution>by The Biotechnology and Biological Sciences Research Council</institution>
</institution-wrap>
</funding-source>
<award-id>E007821/1</award-id>
<award-id>E00797X/1</award-id>
<award-id>BB/K001418 /1</award-id>
</award-group>
</funding-group>
<funding-group specific-use="FundRef">
<award-group>
<funding-source>
<institution-wrap>
<institution>The British Heart Foundation</institution>
</institution-wrap>
</funding-source>
<award-id>FS/09/029/27902</award-id>
</award-group>
</funding-group>
<funding-group specific-use="FundRef">
<award-group>
<funding-source>
<institution-wrap>
<institution>The UK Medical Research Council Metabolic Diseases Unit</institution>
</institution-wrap>
</funding-source>
<award-id>MC_UU_12012/4</award-id>
<award-id>MC_UU_12012/1</award-id>
</award-group>
</funding-group>
<funding-group specific-use="FundRef">
<award-group>
<funding-source>
<institution-wrap>
<institution>The Wellcome Trust</institution>
</institution-wrap>
</funding-source>
<award-id>WT081713</award-id>
<award-id>WT098012</award-id>
</award-group>
</funding-group>
<funding-group specific-use="FundRef">
<award-group>
<funding-source>
<institution-wrap>
<institution>The European Union</institution>
<institution-id>http://search.crossref.org/fundref?q=501100000902</institution-id>
</institution-wrap>
</funding-source>
<award-id>FP7-HEALTH-266408 Full4Health</award-id>
</award-group>
</funding-group>
<funding-group specific-use="FundRef">
<award-group>
<funding-source>
<institution-wrap>
<institution>The Helmholtz Alliance ICEMED</institution>
</institution-wrap>
</funding-source>
</award-group>
</funding-group>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>INTRODUCTION</title>
<p>Nutrition during critical periods of development in early life can exert profound, long-term effects on susceptibility to obesity. For example, men exposed to the Dutch ‘Hunger Winter’ <italic>in utero</italic> during early gestation had an increased risk of developing obesity as adults, whereas obesity rates were reduced amongst those exposed to famine during the last trimester of gestation and in early postnatal life (<xref ref-type="bibr" rid="DMM023903C71">Ravelli et al., 1976</xref>). The early postnatal diet is also important. In randomised trials, full-term infants with low birth weight fed a growth-promoting nutrient-enriched formula had a higher fat mass at the age of 5-8 years than those fed standard formula (<xref ref-type="bibr" rid="DMM023903C77">Singhal et al., 2010</xref>). Studies in rodents, showing that low birth weight followed by rapid postnatal growth is associated with increased adiposity, support findings in humans (<xref ref-type="bibr" rid="DMM023903C68">Plagemann et al., 1992</xref>; <xref ref-type="bibr" rid="DMM023903C20">Cottrell et al., 2011</xref>; <xref ref-type="bibr" rid="DMM023903C5">Berends et al., 2013</xref>). Despite these robust associations, the molecular mechanisms mediating the interaction between early nutrition and obesity risk are still largely unknown.</p>
<p>It is widely acknowledged that the hypothalamus, which in humans develops primarily prenatally but in rodents develops postnatally, plays an important role in the programming of body mass (<xref ref-type="bibr" rid="DMM023903C34">Grove et al., 2005</xref>; <xref ref-type="bibr" rid="DMM023903C41">Horvath and Bruning, 2006</xref>; <xref ref-type="bibr" rid="DMM023903C32">Glavas et al., 2007</xref>). To date, major efforts have been directed at understanding the roles of leptin and insulin in this process (<xref ref-type="bibr" rid="DMM023903C11">Bouret, 2010</xref>; <xref ref-type="bibr" rid="DMM023903C94">Yura et al., 2005</xref>; <xref ref-type="bibr" rid="DMM023903C78">Steculorum and Bouret, 2011</xref>). However, studies in our laboratory using leptin-deficient <italic>ob</italic>/<italic>ob</italic> mice demonstrated that leptin-independent mechanisms are likely to also programme body mass (<xref ref-type="bibr" rid="DMM023903C20">Cottrell et al., 2011</xref>).</p>
<p>The importance of the 5-hydroxytryptamine (5-HT; serotonin) system in the control of food intake and body mass has been recognised for many years and alterations in central serotonergic activity have been observed in obese humans, non-human primates and rodents (<xref ref-type="bibr" rid="DMM023903C60">Mori et al., 1999</xref>; <xref ref-type="bibr" rid="DMM023903C23">De Fanti et al., 2001</xref>; <xref ref-type="bibr" rid="DMM023903C80">Sullivan et al., 2010</xref>). 5-HT is a potent anorectic signal that influences food intake in the mature brain by acting predominantly via 5-HT<sub>2C</sub>R to regulate the key energy balance mediator, pro-opiomelanocortin (POMC), within the arcuate nucleus of the hypothalamus (ARC; <xref ref-type="bibr" rid="DMM023903C24">Doslikova et al., 2013</xref>; <xref ref-type="bibr" rid="DMM023903C15">Burke et al., 2014</xref>). Indeed, disruption of the 5-HT<sub>2C</sub>R gene (<italic>Htr2c</italic>) specifically expressed on POMC neurons programmes hyperphagia and obesity when animals are fed a high-fat diet (<xref ref-type="bibr" rid="DMM023903C7">Berglund et al., 2013</xref>). In addition to playing an important role in energy balance and body mass, 5-HT acts as a trophic factor during fetal brain development in rodents, regulating cell migration, proliferation, maturation and axonal growth (<xref ref-type="bibr" rid="DMM023903C89">Whitaker-Azmitia et al., 1996</xref>; <xref ref-type="bibr" rid="DMM023903C30">Gaspar et al., 2003</xref>). The long-term effects of disturbances in the 5-HT system during early life on obesity risk are, however, not fully defined.</p>
<p>Here, we used an unbiased genome-wide profiling approach to identify differentially expressed targets in the hypothalamus of intrauterine protein-restricted rats that underwent postnatal catch-up growth (recuperated animals) in an effort to elucidate the molecular mechanisms that mediate the effects of early nutrition on energy balance.</p>
</sec>
<sec id="s2" sec-type="results">
<title>RESULTS</title>
<sec id="s2a">
<title>Growth trajectories, body and brain mass</title>
<p>At birth, offspring of mothers fed a low protein diet during pregnancy were significantly smaller than the control pups (<italic>P</italic>&lt;0.001) (<xref ref-type="table" rid="DMM023903TB1">Table 1</xref>A). The body mass of the recuperated pups caught up with that of control pups by postnatal day (P)14 and they weighed the same as controls at weaning (<xref ref-type="table" rid="DMM023903TB1">Table 1</xref>A). Fractional growth rate did not differ between recuperated and control pups between birth and P7 (0.16±0.1 vs 0.17±0.01); however, recuperated offspring had significantly higher fractional growth rate between birth and P14 and P21 when compared with controls (P14: 0.31±0.01 vs 0.24±0.01, <italic>P</italic>&lt;0.001; P21: 0.38±0.01 vs 0.29±0.01, <italic>P</italic>&lt;0.001). At 3 months of age, body masses were similar between recuperated and control offspring. Brain masses were similar between the experimental animals and their age-matched controls at both P22 and 3 months of age, in both absolute terms and relative to body mass (<xref ref-type="table" rid="DMM023903TB1">Table 1</xref>B). These findings demonstrate that maternal low-protein diet decreases <italic>in utero</italic> growth of the offspring so that they have a lower birth weight. These animals then undergo ‘catch up’ growth such that by P22, they have the same body mass as the control offspring.
<table-wrap id="DMM023903TB1" orientation="portrait" position="float"><label>Table 1.</label><caption><p><bold>Growth trajectories, body and brain mass in offspring exposed <italic>in utero</italic> to maternal low-protein diet that underwent accelerated postnatal growth</bold></p></caption><graphic xlink:href="dmm-9-023903-i1"></graphic></table-wrap></p>
</sec>
<sec id="s2b">
<title>Levels of 5-HT and tryptophan in mothers and offspring</title>
<sec id="s2b1">
<title>Maternal, placental and amniotic fluid 5-HT and tryptophan levels</title>
<p>Tryptophan is an essential amino acid and is required for 5-HT synthesis. A low-protein diet would therefore be expected to yield low plasma tryptophan levels. We analysed the levels of 5-HT and tryptophan in the dams, placenta and amniotic fluid to investigate whether 5-HT might be a programming factor that mediates changes in appetite and susceptibility to diet-induced obesity in recuperated animals. As expected, at embryonic day (E)16.5, we observed reduced levels of tryptophan in the serum of dams fed a low-protein diet (‘low-protein’) compared with control dams (158±17 mmol l<sup>−1</sup> vs 220±20 mmol l<sup>−1</sup>, <italic>P</italic>&lt;0.05). Paradoxically, the serum 5-HT level was raised in low-protein dams at this time point (<italic>P</italic>&lt;0.05; <xref ref-type="fig" rid="DMM023903F1">Fig. 1</xref>A). A similar pattern was observed for tryptophan and 5-HT concentrations in the amniotic fluid at E16.5, with tryptophan levels reduced in the amniotic fluid from low protein pregnancies (26.3±3.2 mmol l<sup>−1</sup> vs 40.6±3.4 mmol l<sup>−1</sup>, <italic>P</italic>&lt;0.01, <italic>n</italic>=10-11 per group), whereas 5-HT levels were raised (65.0±6.6 nmol l<sup>−1</sup> vs 48.2±3.9 nmol l<sup>−1</sup>, <italic>P</italic>&lt;0.05, <italic>n</italic>=10-11 per group). 5-HT levels were also significantly increased in E16.5 placentas from low-protein pregnancies when compared with control pregnancies (<italic>P</italic>&lt;0.01; <xref ref-type="fig" rid="DMM023903F1">Fig. 1</xref>A). Furthermore, we observed a negative correlation between placental 5-HT level and maternal serum tryptophan (<italic>P</italic>&lt;0.05; <xref ref-type="fig" rid="DMM023903F1">Fig. 1</xref>B). There was a positive correlation between placental 5-HT and fetal brain 5-HT levels (<xref ref-type="fig" rid="DMM023903F1">Fig. 1</xref>C). These findings reveal that in response to significantly reduced dietary tryptophan, 5-HT is overproduced in the mother and in the intrauterine environment in which the fetus grows and develops.
<fig id="DMM023903F1" orientation="portrait" position="float"><label>Fig. 1.</label><caption><p><bold>Effects of maternal nutrition on 5-HT levels in low-protein and control pregnancies, and neonatal pups</bold>. (A) 5-HT levels in maternal serum, the placenta, fetal brain (all analysed at E16.5) and neonatal hypothalamus. Data analysed using unpaired Student's <italic>t</italic>-test and presented as mean percentage of control; for maternal serum 5-HT, <italic>n</italic>=6; placenta 5-HT, <italic>n</italic>=16; fetal brain 5-HT, <italic>n</italic>=10; neonatal hypothalamus, <italic>n</italic>=12 per group. (B,C) Correlation between maternal, placental and fetal 5-HT levels. (B) Correlation between placental 5-HT and maternal serum tryptophan, analysed using Pearson correlation coefficient because data were normally distributed; <italic>n</italic>=6 per group. (C) Correlation between placental 5-HT and fetal head 5-HT analysed using Spearman correlation coefficient because data were not normally distributed. <italic>n</italic>=10 per group; <italic>n</italic> represents number of litters. *<italic>P</italic>&lt;0.05; **<italic>P</italic>&lt;0.01.</p></caption><graphic xlink:href="dmm-9-023903-g1"></graphic></fig></p>
</sec>
<sec id="s2b2">
<title>Fetal, neonatal, weaning and adult tryptophan and 5-HT levels</title>
<p>Likewise, in the neonatal brain, a decrease in tryptophan levels (67.9±13.6 mmol l<sup>−1</sup> vs 140±14.7 mmol l<sup>−1</sup>, <italic>P</italic>&lt;0.01) was associated with an increase in 5-HT levels in the hypothalami of recuperated pups at birth (<italic>P</italic>&lt;0.01; <xref ref-type="fig" rid="DMM023903F1">Fig. 1</xref>A). 5-HT levels were also increased in the brains of E16.5 fetuses from low-protein pregnancies (<xref ref-type="fig" rid="DMM023903F1">Fig. 1</xref>A). By weaning as well as at 3 months, hypothalamic 5-HT levels were normalised to control levels (P21: recuperated, 1347±110 mmol l<sup>−1</sup> vs control, 1659±131 pmol g<sup>−1</sup>; <italic>n</italic>=12 per group; 3 months: recuperated, 1414±154 mmol l<sup>−1</sup> vs control, 1354±85 pmol g<sup>−1</sup>; <italic>n</italic>=10 per group). These data indicate that the overproduction of 5-HT in response to a maternal low-protein diet is normalised by weaning.</p>
</sec>
</sec>
<sec id="s2c">
<title>Effect of D-fenfluramine on food intake</title>
<p>We next assessed the significance of maternal diet-stimulated increase in 5-HT during early development of the offspring for the function of the adult 5-HT system. D-fenfluramine is a pharmacological probe of the endogenous 5-HT system that works by stimulating endogenous 5-HT release and blocking its reuptake. D-fenfluramine was prescribed until the 1990s for human obesity treatment because increasing endogenous 5-HT bioavailability reduces appetite and body weight (<xref ref-type="bibr" rid="DMM023903C50">Lam et al., 2010</xref>; <xref ref-type="bibr" rid="DMM023903C55">Marston et al., 2011</xref>). We administered D-fenfluramine into the third ventricle of rats at 3 months and observed the expected reduction in food intake in controls (<xref ref-type="fig" rid="DMM023903F2">Fig. 2</xref>). However, recuperated offspring had impaired sensitivity to the 5-HT-stimulated (D-fenfluramine) food intake reduction (<italic>P</italic>&lt;0.05) (<xref ref-type="fig" rid="DMM023903F2">Fig. 2</xref>). These results show that a low-protein maternal diet followed by accelerated postnatal growth diminishes 5-HT-mediated control of food intake in the adult offspring. Given the strong inverse correlation between 5-HT and appetite, these findings led us to hypothesise that a deregulated 5-HT system might contribute to the programmed increased food intake in these offspring when exposed to an obesogenic diet.
<fig id="DMM023903F2" orientation="portrait" position="float"><label>Fig. 2.</label><caption><p><bold>Effects of maternal protein restriction on food intake in 3-month-old offspring following central administration of D-fenfluramine (Dex)</bold><bold>.</bold> Food consumption during the 2 h following lights out expressed as a percentage of the saline dosed group. Difference between the groups analysed by one-way ANOVA to saline for control and recuperated offspring. <italic>n</italic>=6 per group with <italic>n</italic> representing number of litters. The following numbers of animals were used for each experimental group: control saline, <italic>n</italic>=18 rats; control Dex, <italic>n</italic>=20; recuperated saline; <italic>n</italic>=17; recuperated Dex, <italic>n</italic>=20 rats. D-fenfluramine was administered at 250 nmoles in 2.5 μl of saline. *<italic>P</italic>&lt;0.05 for control Dex versus recuperated Dex. ***<italic>P</italic>&lt;0.001 for control saline versus control Dex.</p></caption><graphic xlink:href="dmm-9-023903-g2"></graphic></fig></p>
</sec>
<sec id="s2d">
<title>Fetal, neonatal and postnatal expression of <italic>Htr2c</italic> in the hypothalamus</title>
<p>5-HT is a neurotransmitter that communicates appetite-related signals primarily through the 5-HT<sub>2C</sub>R within the ARC. If the effects of 5-HT on appetite are diminished in recuperated rats, this suggests a perturbation in signalling at the 5-HT<sub>2C</sub>R. We next probed the consequence of elevated 5-HT during development on the expression of the 5-HT<sub>2C</sub>R. Analysis of <italic>Htr2c</italic> mRNA expression in E16.5 fetal brain showed significantly reduced levels in the whole heads of fetuses from low-protein pregnancies (<italic>P</italic>&lt;0.05; <xref ref-type="fig" rid="DMM023903F3">Fig. 3</xref>A). At birth, the <italic>Htr2c</italic> transcript level was still reduced in the hypothalamus of the growth-restricted pups (<italic>P</italic>&lt;0.001; <xref ref-type="fig" rid="DMM023903F3">Fig. 3</xref>A) as was 5-HT<sub>2C</sub>R protein (<italic>P</italic>&lt;0.001; <xref ref-type="fig" rid="DMM023903F3">Fig. 3</xref>B,C). However, by 3 months, no significant differences in mRNA levels were observed between the experimental groups (<xref ref-type="fig" rid="DMM023903F3">Fig. 3</xref>A). Protein expression was, however, still significantly reduced in the hypothalamus of recuperated animals at 3 months (<italic>P</italic>&lt;0.05; <xref ref-type="fig" rid="DMM023903F3">Fig. 3</xref>B,C). Given that perturbations of ARC 5-HT<sub>2C</sub>R function increases appetite and body mass (<xref ref-type="bibr" rid="DMM023903C7">Berglund et al., 2013</xref>), these results reveal a potential mechanism through which rapid postnatal growth is achieved in recuperated rats, which could also contribute to increased susceptibility to diet-induced obesity in these animals.
<fig id="DMM023903F3" orientation="portrait" position="float"><label>Fig. 3.</label><caption><p><bold>Effects of maternal protein restriction on central <italic>Htr2c</italic> mRNA and 5-HT<sub>2C</sub>R protein expression in the offspring.</bold> (A) <italic>Htr2c</italic> mRNA levels as measured using qRT-PCR. Gene expression data was normalised to <italic>Ppia</italic>. (B) Analysis of 5-HT<sub>2C</sub>R protein levels from western blot data. (C) Western blots. 20 mg and 10 mg of pooled samples were loaded in the middle of the gels to ensure the linearity of the signal. Data were analysed using unpaired Student's <italic>t</italic>-test and presented as mean±s.e.m. for RNA data and percentages relative to control for protein data; <italic>n</italic>=8 per group, <italic>n</italic> represents number of litters. *<italic>P</italic>&lt;0.05; ***<italic>P</italic>&lt;0.001.</p></caption><graphic xlink:href="dmm-9-023903-g3"></graphic></fig></p>
</sec>
<sec id="s2e">
<title>Microarray analysis of ARC from control and recuperated 3-month-old offspring</title>
<p>5-HT is a trophic factor during fetal brain development influencing both 5-HT circuits and the anatomical organisation of other systems (<xref ref-type="bibr" rid="DMM023903C89">Whitaker-Azmitia et al., 1996</xref>; <xref ref-type="bibr" rid="DMM023903C30">Gaspar et al., 2003</xref>). The ARC is a crucial regulator of energy balance. Having demonstrated that maternal diet induces changes in offspring 5-HT and disrupts the functioning of the 5-HT appetite system, we next probed whether 5-HT disrupts other ARC genes and circuits regulating appetite. To achieve this, we performed laser-capture microdissection (LCM) of the ARC of 3-month-old control and recuperated rats and subjected samples to microarray analysis.</p>
<sec id="s2e1">
<title>Validation of laser-capture microdissection</title>
<p>To ensure the specificity of the ARC dissection within the LCM material (<xref ref-type="fig" rid="DMM023903F4">Fig. 4</xref>), we analysed the expression of two genes that are not expressed in the ARC but are expressed in the neighbouring hypothalamic nuclei. Neither <italic>Brn1</italic> (also known as <italic>Pou3f3</italic>), which is specific to the paraventricular nucleus (PVN) nor <italic>Sf-1</italic> (also known as <italic>Nr5a1</italic>), which is found in the ventromedial nucleus of the hypothalamus (VMN), were detected (data not shown). In addition, we examined the expression of four key genes involved in the regulation of energy balance in the ARC: <italic>Pomc</italic>, <italic>Agrp</italic>, <italic>Cart</italic><italic>pt</italic> and <italic>Npy</italic>. We confirmed that all of these genes were highly expressed in the dissected material using Taqman RT-PCR (data not shown).
<fig id="DMM023903F4" orientation="portrait" position="float"><label>Fig. 4.</label><caption><p><bold>Laser-capture microdissection (LCM) of the hypothalamic ARC of 3-month-old rats and microarray analysis results.</bold> (A) LCM of the ARC (−4.52 to −2.30 mm relative to Bregma). Brain atlas image was taken from <xref ref-type="bibr" rid="DMM023903C65">Paxinos and Watson (1998)</xref>. 3V, 3rd ventricle; ArcD, arcuate nucleus, dorsal part; ArcL, arcuate nucleus, lateral part; ArcM, arcuate nucleus, medial part; DMC, dorsomedial nucleus, compact part; DMD, dorsomedial nucleus, dorsal part; DMV, dorsomedial nucleus, ventral part; MEI, internal layer; MEE, median eminence, external layer; Pe, periventricular hypothalamic nucleus; PH, posterior hypothalamic nucleus; PeF, perifornical nucleus; TC, tuber cinereum area; VMHC, ventromedial nucleus, central part; VMHDM, ventromedial nucleus, dorsomedial part; VMHVL, ventromedial nucleus, ventrolateral part. (B,C) Venn diagrams showing the effects of maternal protein restriction followed by catch-up growth on the expression of genes in the ARC of male 3-month-old offspring, according to three different, robust, analyses: GeneChip operating software (GCOS), GeneChip robust multi-array averaging (GC-RMA) and robust multi-array averaging (RMA). Genes were considered to be up- or downregulated if the 1.3-fold threshold was reached and <italic>P</italic>&lt;0.05. (B) Upregulated genes and (C) downregulated genes in the recuperated animals when compared with controls. The sizes of circles and numbers in parentheses indicate the number of genes as identified by either the GCOS, RMA or GC-RMA algorithms. For microarray analysis <italic>n</italic>=6 chips per group, <italic>n</italic> represents number of litters.</p></caption><graphic xlink:href="dmm-9-023903-g4"></graphic></fig></p>
</sec>
<sec id="s2e2">
<title>Analysis of microarrays using three different algorithms and pathway analysis</title>
<p>Following global transcriptional profiling, we analysed the data using three different algorithms: (1) GeneChip operating software (GCOS), (2) robust multi-array averaging (RMA) and (3) GeneChip robust multi-array averaging (GCRMA), to ensure maximum stringency and to reduce the number of false positives. The combined analysis, using a 1.3-fold cut-off threshold and <italic>P</italic>&lt;0.05, revealed that out of 31,099 genes analysed, expression of 15,951 genes was detected in the ARC. Of these, 142 genes were upregulated in the ARC of the recuperated animals, whereas 59 genes were downregulated (<xref ref-type="fig" rid="DMM023903F4">Fig. 4</xref>B,C, respectively). The top 25 up- and downregulated genes in recuperated offspring are presented in <xref ref-type="table" rid="DMM023903TB2">Tables 2</xref> and <xref ref-type="table" rid="DMM023903TB3">3</xref>. <italic>Htr2a</italic>, which encodes 5-HT<sub>2A</sub>R, was the gene with the highest (2.55-fold) increase. We further analysed the microarray data using Ingenuity Pathway analysis software to detect groups of functionally related genes. The top three gene functions affected by early nutrition in 3-month-old male recuperated rats were cell cycle, connective tissue development and function, cellular growth and proliferation (<xref ref-type="table" rid="DMM023903TB4">Table 4</xref>).
<table-wrap id="DMM023903TB2" orientation="portrait" position="float"><label>Table 2.</label><caption><p><bold>Genes in the ARC that are upregulated in recuperated 3-month-old male rats</bold></p></caption><graphic xlink:href="dmm-9-023903-i2"></graphic></table-wrap>
<table-wrap id="DMM023903TB3" orientation="portrait" position="float"><label>Table 3.</label><caption><p><bold>Genes in the ARC that are downregulated in recuperated 3-month-old male rats</bold></p></caption><graphic xlink:href="dmm-9-023903-i3"></graphic></table-wrap>
<table-wrap id="DMM023903TB4" orientation="portrait" position="float"><label>Table 4.</label><caption><p><bold>RMA Plier gene function analysis for recuperated offspring compared with controls</bold></p></caption><graphic xlink:href="dmm-9-023903-i4"></graphic></table-wrap></p>
</sec>
<sec id="s2e3">
<title>Validation of genes identified by microarray</title>
<p>Out of the seven genes chosen for validation, two genes had very low expression (<italic>Plau</italic> and <italic>Pde4a</italic>). Out of five genes remaining, differential expression of three genes (<italic>Htr2a</italic>, <italic>Khsrp</italic> and <italic>Retsat</italic>) was confirmed by RT-PCR, whereas two genes were not validated (<italic>Car8</italic> and <italic>Eef2k</italic>) (<xref ref-type="fig" rid="DMM023903F5">Fig. 5</xref>A). As <italic>Htr2a</italic> had the highest fold change in the microarray analysis (<xref ref-type="table" rid="DMM023903TB2">Table 2</xref>), it was further investigated. The upregulation of <italic>Htr2a</italic> in the ARC of 3-month-old recuperated animals (<italic>P</italic>&lt;0.05) observed using RT-PCR was confirmed by <italic>in situ</italic> hybridisation (<italic>P</italic>&lt;0.05; <xref ref-type="fig" rid="DMM023903F5">Fig. 5</xref>B).
<fig id="DMM023903F5" orientation="portrait" position="float"><label>Fig. 5.</label><caption><p><bold>Validation of the differentially expressed genes identified using microarray approach as being regulated by early nutrition.</bold> (A) Validation of the differentially expressed genes in the ARC of 3-month-old control and recuperated offspring. Analysis was carried out using Taqman qRT-PCR. Gene expression data is normalised to <italic>Ppia.</italic> Data were analysed using a two-tailed unpaired Student's <italic>t</italic>-test. (B) Validation of <italic>Htr2a</italic> mRNA expression in the ARC using ISHH. (C) <italic>Htr2a</italic> mRNA expression in rats at P3 and P22 in the ARC. (D) <italic>Htr2a</italic> mRNA expression in 3-month-old rats in the VMN using ISHH. (E) <italic>Htr2a</italic> mRNA expression in 3 and 22 day old rats in the VMN. (F) Localisation of <italic>Htr2a</italic> on ARC POMC neurons in 3-month-old control rats detected using ISHH for [<sup>35</sup>S]<italic>Htr2a</italic> and chromogenic IHC for α-MSH. Dense black granular staining directly overlapping brown α-MSH cell body and axons indicates the presence of <italic>Htr2a</italic> on POMC neurons. Scale bars: 200 µm for ARC image, 10 µm in the inset. Data were analysed using two-tailed Student's <italic>t</italic>-test in B,D; a two-way ANOVA was used with appropriate Duncan's <italic>post hoc</italic> test for C,E. Values are expressed as means±s.e.m. For A,B,D, <italic>n</italic>=8 per group; for C,E, <italic>n</italic>=6-8 per group, <italic>n</italic> represents number of litters. *<italic>P</italic>&lt;0.05; **<italic>P</italic>&lt;0.01. 3V, 3rd ventricle; ME, median eminence.</p></caption><graphic xlink:href="dmm-9-023903-g5"></graphic></fig></p>
</sec>
</sec>
<sec id="s2f">
<title>Timing and location of increased hypothalamic <italic>Htr2a</italic> expression</title>
<p>A similar pattern of <italic>Htr2a</italic> expression to that seen in 3-month-old animals was observed at P22. <italic>Htr2a</italic> was significantly elevated in the ARC of recuperated rats at weaning (<italic>P</italic>&lt;0.05; <xref ref-type="fig" rid="DMM023903F5">Fig. 5</xref>C). Expression of <italic>Htr2a</italic> was, however, not altered in neonatal ARC (<xref ref-type="fig" rid="DMM023903F5">Fig. 5</xref>C) or in E16.5 fetal brains (low-protein, 0.933±0.035; control, 1.002±0.022). As in the ARC, expression of <italic>Htr2a</italic> was also significantly increased in VMN of 3-month-old recuperated animals (<italic>P</italic>&lt;0.05; <xref ref-type="fig" rid="DMM023903F5">Fig. 5</xref>D,E). However, in contrast to the ARC, no difference was seen in <italic>Htr2a</italic> expression within VMN between the two experimental groups at P22 (<xref ref-type="fig" rid="DMM023903F5">Fig. 5</xref>E), suggesting that upregulation of <italic>Htr2a</italic> within the VMN in the recuperated group is secondary to the upregulation of this receptor in the ARC. Overall, these findings reveal a change in 5-HT<sub>2A</sub>R receptor expression using an unbiased genome-wide profiling approach and thereby support the importance of maternal diet in inducing changes in the 5-HT system within the offspring hypothalami that may deregulate offspring energy balance.</p>
</sec>
<sec id="s2g">
<title>Neuronal colocalisation of ARC 5-HT<sub>2A</sub>R and POMC</title>
<p>Within the ARC, 5-HT primarily influences energy balance by 5-HT<sub>2C</sub>R stimulation of POMC neuronal activity (<xref ref-type="bibr" rid="DMM023903C37">Heisler et al., 2002</xref>; <xref ref-type="bibr" rid="DMM023903C91">Xu et al., 2008</xref>; <xref ref-type="bibr" rid="DMM023903C7">Berglund et al., 2013</xref>; <xref ref-type="bibr" rid="DMM023903C15">Burke et al., 2014</xref>). Given that <italic>Htr2a</italic> expression is reduced in rats exposed to a maternal low-protein diet, we hypothesised that <italic>Htr2a</italic> might therefore be upregulated to compensate for this in an effort to normalise energy balance. To determine whether 5-HT<sub>2A</sub>Rs are anatomically positioned to influence the activity of POMC neurons, we visualised co-expression using dual histochemical labelling. We determined that ∼40% of the ARC POMC neurons express <italic>Htr2a</italic> in control rats (<xref ref-type="fig" rid="DMM023903F5">Fig. 5</xref>F). These data reveal a defined population of neurons within the ARC involved in regulation of body mass that could be influenced by G<sub>q</sub>-protein coupled 5-HT<sub>2A</sub>Rs.</p>
</sec>
<sec id="s2h">
<title>Effect of 5-HT<sub>2A</sub>R agonism on food intake</title>
<p>To assess the functional implications of upregulated ARC <italic>Htr2a</italic> expression, we administered the selective 5-HT<sub>2A</sub>R agonist TCB2 [(4-bromo-3,6-dimethoxybenzocyclobuten-1-yl) methylamine hydrobromide] directly into the third ventricle and measured its effects on food intake in adult 3-month-old recuperated and control offspring. We confirmed previous results showing that 5-HT<sub>2A</sub>R agonism significantly suppresses food intake (<xref ref-type="bibr" rid="DMM023903C27">Fox et al., 2010</xref>). TCB2 also significantly decreased food intake in the recuperated offspring, as shown by two-way ANOVA analysis (overall effect of TCB2 administration, <italic>P</italic>&lt;0.001; <xref ref-type="fig" rid="DMM023903F6">Fig. 6</xref>). However, the dose-response curves between the control and recuperated groups were significantly different (<italic>P</italic>&lt;0.05; <xref ref-type="fig" rid="DMM023903F6">Fig. 6</xref>). Recuperated offspring were more sensitive than the controls to the centrally administered action of 5-HT<sub>2A</sub>R agonist TCB2 (overall effect of early nutrition, <italic>P</italic>&lt;0.05; <xref ref-type="fig" rid="DMM023903F6">Fig. 6</xref>). These results reveal that overexpressed 5-HT<sub>2A</sub>Rs in recuperated rats are functional and when pharmacologically stimulated, a greater net effect on appetite is achieved. Extrapolation of these findings to endogenous 5-HT activity, as indicated by the D-fenfluramine results, suggests that the upregulation of 5-HT<sub>2A</sub>R is insufficient to compensate for downregulation of 5-HT<sub>2C</sub>R in the regulation of appetite by 5-HT.
<fig id="DMM023903F6" orientation="portrait" position="float"><label>Fig. 6.</label><caption><p><bold>Effects of maternal protein restriction on food intake following central administration of the 5-HT<sub>2A</sub>R agonist TCB2 in 3-month-old rats.</bold> Food consumption during the 2 h following lights out expressed as a percentage of the saline dosed group. Differences between the groups were analysed using two-way ANOVA (overall effect of TCB2 administration, <italic>P</italic>&lt;0.001; overall effect of early nutrition, <italic>P</italic>&lt;0.05) followed by Bonferroni's multiple comparison test. <italic>n</italic>=13-15 per group, <italic>n</italic> represents number of litters. *<italic>P</italic>&lt;0.05.</p></caption><graphic xlink:href="dmm-9-023903-g6"></graphic></fig></p>
</sec>
</sec>
<sec id="s3" sec-type="discussion">
<title>DISCUSSION</title>
<p>Evidence from epidemiological studies and animal models shows that suboptimal early nutrition affects susceptibility to obesity in later life. We and others have shown that rodents exposed to maternal protein restriction <italic>in utero</italic> and accelerated postnatal growth (recuperated offspring) are more susceptible to development of diet-induced obesity (<xref ref-type="bibr" rid="DMM023903C63">Ozanne et al., 2004</xref>; <xref ref-type="bibr" rid="DMM023903C8">Bieswal et al., 2006</xref>). In the current study, we focused on 3-month-old recuperated rats fed a chow diet that are a similar weight to control offspring. This enabled us to investigate mechanisms mediating the effects of early nutrition on susceptibility to developing diet-induced obesity without the confounding effects of obesity itself. In recent years, leptin has been studied as a key factor involved in programming of obesity risk (<xref ref-type="bibr" rid="DMM023903C21">Cripps et al., 2009</xref>; <xref ref-type="bibr" rid="DMM023903C12">Bouret et al., 2004</xref>). However, we previously showed that programming of increased adiposity is, at least in part, independent of leptin (<xref ref-type="bibr" rid="DMM023903C20">Cottrell et al., 2011</xref>). In the current study, we investigated the effect of a maternal low-protein diet during gestation on a factor directly impacted by reduced dietary protein, 5-HT. We observed that 5-HT levels were increased in the fetal brains and neonatal hypothalami of rats exposed to a low-protein diet <italic>in utero</italic>. Because 5-HT is known as an essential growth and regulatory factor that drives the development and maturation of its own cellular network and related neuronal systems (<xref ref-type="bibr" rid="DMM023903C67">Pino et al., 2004</xref>; <xref ref-type="bibr" rid="DMM023903C61">Oberlander, 2012</xref>), an excess of 5-HT might lead to impaired interneuron migration and abnormal development of the serotonergic system itself and its target regions (<xref ref-type="bibr" rid="DMM023903C67">Pino et al., 2004</xref>; <xref ref-type="bibr" rid="DMM023903C61">Oberlander, 2012</xref>). Here, we suggest that elevated hypothalamic levels of 5-HT in recuperated animals in early life cause developmental and functional alterations that increase susceptibility to obesity later in life.</p>
<p>We observed reduced maternal circulating tryptophan but increased 5-HT in pregnant dams fed a low-protein diet. This could be a consequence of (1) the increased carbohydrate content in the low-protein diet, which was added to balance protein reduction to obtain an isocaloric diet and (2) the dams' increased food intake in both absolute and relative terms (<xref ref-type="bibr" rid="DMM023903C26">Fernandez-Twinn et al., 2003</xref>). Such dietary intervention can affect maternal insulin levels. Low-protein dams were shown to be hyperinsulinaemic at day 14 of pregnancy (<xref ref-type="bibr" rid="DMM023903C26">Fernandez-Twinn et al., 2003</xref>). As circulating tryptophan levels decrease in an insulin-dose-dependent manner, the increased insulin concentration in these dams could contribute to the reduced tryptophan levels (<xref ref-type="bibr" rid="DMM023903C26">Fernandez-Twinn et al., 2003</xref>; <xref ref-type="bibr" rid="DMM023903C28">Fukagawa et al., 1987</xref>). Another possibility is that the dietary intervention has altered the gastrointestinal microbiome of the dam. Diet is the key regulator of both taxa and microbiota production of metabolites (<xref ref-type="bibr" rid="DMM023903C76">Scott et al., 2013</xref>). More than 90% of 5-HT in the body is synthesised in the gut, and the microbiota has been shown to play a crucial role in regulating host 5-HT biosynthesis and 5-HT blood levels (<xref ref-type="bibr" rid="DMM023903C93">Yano et al., 2015</xref>).</p>
<p>Several mechanisms might be involved in mediating the relationship between reduced maternal circulating tryptophan and increased 5-HT in the brains of their unborn offspring. In adult rats, food deprivation leads to an increase in the concentration of circulating free fraction of tryptophan (FFT), the fraction that passes through the blood-brain barrier (<xref ref-type="bibr" rid="DMM023903C48">Knott and Curzon, 1972</xref>; <xref ref-type="bibr" rid="DMM023903C66">Perez-Cruet et al., 1972</xref>). Raised circulating FFT and increases in tryptophan uptake by serotonergic neurons, the activity of tryptophan-5-hydroxylase and synthesis of 5-HT have also been reported in intrauterine growth-restricted (IUGR) rat pups and infants (<xref ref-type="bibr" rid="DMM023903C46">Kalyanasundaram, 1976</xref>; <xref ref-type="bibr" rid="DMM023903C39">Hernandez et al., 1989</xref>; <xref ref-type="bibr" rid="DMM023903C53">Manjarrez et al., 1996</xref><xref ref-type="bibr" rid="DMM023903C54">, 1998</xref>). Upregulation of FFT in IUGR was attributed to abnormal kinetics of tryptophan binding to albumin (<xref ref-type="bibr" rid="DMM023903C40">Hernandez-Rodriguez et al., 2009</xref>). Reduced plasma levels of leucine, isoleucine and tyrosine, which compete with tryptophan for entry into brain, might also contribute to an increase in the transport of tryptophan across the blood-brain barrier in IUGR pups (<xref ref-type="bibr" rid="DMM023903C74">Roux and Jahchan, 1974</xref>).</p>
<p>In recent years, in both mice and humans, the placenta has emerged as an important source of 5-HT, that can directly impact fetal brain development (<xref ref-type="bibr" rid="DMM023903C10">Bonnin et al., 2011</xref>). In our study, the impact of maternal low-protein diet on 5-HT was more pronounced in the placenta and fetal brain than in the dam. This supports the proposal that the placenta is cannibalised in response to maternal food deprivation to provide nutrients and substrates for the developing hypothalamus (<xref ref-type="bibr" rid="DMM023903C13">Broad and Keverne, 2011</xref>). We observed an association between levels of placental 5-HT and fetal brain 5-HT at E16.5 – the time-point at which 5-HT fibres can be detected in the hypothalamus and both exogenous and endogenous sources of 5-HT contribute to fetal 5-HT synthesis (<xref ref-type="bibr" rid="DMM023903C2">Aitken and Tork, 1988</xref>; <xref ref-type="bibr" rid="DMM023903C10">Bonnin et al., 2011</xref>). Increased 5-HT production within the placenta might contribute to raised 5-HT levels in fetal brains from low-protein dams. Maternal tryptophan levels have also been reported to influence central 5-HT levels in the offspring and maternal peripheral 5-HT proved to be important for offspring neurodevelopment (<xref ref-type="bibr" rid="DMM023903C9">Bonnin and Levitt, 2011</xref>; <xref ref-type="bibr" rid="DMM023903C19">Cote et al., 2007</xref>). This suggests that both maternal and placental tryptophan/5-HT metabolism are part of an important molecular pathway for fetal programming of the 5-HT system and brain development.</p>
<p>Changes in 5-HT bioavailability not only impact formation of hypothalamic circuitry during development but have also been shown to influence appetite and body mass in the adult (<xref ref-type="bibr" rid="DMM023903C69">Pôrto et al., 2009</xref>; <xref ref-type="bibr" rid="DMM023903C6">Berg et al., 2013</xref>; <xref ref-type="bibr" rid="DMM023903C52">Madden and Zup, 2014</xref>). 5-HT primarily regulates energy balance via activity at the G<sub>q</sub>-coupled receptor, 5-HT<sub>2C</sub>R. Here we report that elevated fetal 5-HT could potentially programme decreased levels of hypothalamic 5-HT<sub>2C</sub>R, although direct evidence for this relationship remains to be established. The reduction in 5-HT<sub>2C</sub>R could be an early and permanent developmental consequence of central hyperserotonemia. Reduced 5-HT<sub>2C</sub>R function is known to promote increased appetite and obesity. Specifically, genetic inactivation of <italic>Htr2c</italic>, leads to lifelong hyperphagia and elevated body mass in mice fed standard chow diet (<xref ref-type="bibr" rid="DMM023903C83">Tecott et al., 1995</xref>), whereas pharmacological activation of these receptors reduces food intake and decreases body mass (<xref ref-type="bibr" rid="DMM023903C37">Heisler et al., 2002</xref>; <xref ref-type="bibr" rid="DMM023903C35">Halford and Harrold, 2012</xref>; <xref ref-type="bibr" rid="DMM023903C15">Burke et al., 2014</xref>). 5-HT<sub>2C</sub>Rs are involved in mediating the action of D-fenfluramine, which stimulates the release of 5-HT and inhibits the re-uptake of 5-HT into nerve terminals (<xref ref-type="bibr" rid="DMM023903C87">Vickers et al., 2001</xref>; <xref ref-type="bibr" rid="DMM023903C85">Trifunovic and Reilly, 2006</xref>; <xref ref-type="bibr" rid="DMM023903C92">Xu et al., 2010</xref>). Moreover, the subpopulation of 5-HT<sub>2C</sub>Rs expressed solely with POMC is sufficient to mediate D-fenfluramine and 5-HT<sub>2C</sub>R agonist mCPP appetite suppression (<xref ref-type="bibr" rid="DMM023903C91">Xu et al., 2008</xref>). Following the administration of D-fenfluramine into the third ventricle, we observed impaired sensitivity to 5-HT-stimulated food reduction in 3-month-old recuperated animals. As the functional capacity of 5-HT<sub>2C</sub>R is dependent upon availability of active membrane receptor pools, the impaired response to D-fenfluramine in recuperated animals is probably a consequence of reduced 5-HT<sub>2C</sub>R protein levels in the hypothalamus of these animals.</p>
<p>We used LCM of the ARC combined with microarray analysis to identify differentially expressed genes that could be affected by early hyperserotonemia. We found that <italic>Khsrp</italic> expression was increased in 3-month-old recuperated offspring. <italic>Khsrp</italic>, which encodes KH-type splicing regulatory protein, is involved in the control of mRNA decay (<xref ref-type="bibr" rid="DMM023903C31">Gherzi et al., 2006</xref>; <xref ref-type="bibr" rid="DMM023903C75">Ruggiero et al., 2007</xref>) and plays a key role in the translation of DNA damage signalling to miRNA biogenesis (<xref ref-type="bibr" rid="DMM023903C84">Trabucchi et al., 2009</xref>; <xref ref-type="bibr" rid="DMM023903C96">Zhang et al., 2011</xref>). Although recuperated animals have reduced longevity (<xref ref-type="bibr" rid="DMM023903C45">Jennings et al., 1999</xref>), which is associated with increased oxidative stress and an impaired response to DNA damage (<xref ref-type="bibr" rid="DMM023903C81">Tarry-Adkins et al., 2008</xref><xref ref-type="bibr" rid="DMM023903C82">, 2009</xref>), the functional significance of the increase in KHSRP in the brain of these animals remains to be determined.</p>
<p><italic>Htr2a</italic> is another gene that was increased in the 3-month-old recuperated offspring<italic>.</italic> The precise role that <italic>Htr2a</italic> plays in the regulation food intake has not been fully defined<italic>.</italic>
<italic>Htr2a</italic> was upregulated in the ARC of diet-induced obese rats (<xref ref-type="bibr" rid="DMM023903C64">Park et al., 1999</xref>), whereas in humans, 5-HT<sub>2A</sub>R correlated positively with BMI and a polymorphism in the gene encoding 5-HT<sub>2A</sub>R has been associated with obesity (<xref ref-type="bibr" rid="DMM023903C73">Rosmond et al., 2002</xref>; <xref ref-type="bibr" rid="DMM023903C25">Erritzoe et al., 2009</xref>; <xref ref-type="bibr" rid="DMM023903C16">Carr et al., 2013</xref>). However, knockout of <italic>Htr2a</italic> in mice does not alter food consumption or gain in body mass when mice are fed laboratory chow (<xref ref-type="bibr" rid="DMM023903C88">Weisstaub et al., 2006</xref>), suggesting the presence of developmental compensatory mechanisms or that body mass gain only occurs when these mice are placed on an obesogenic diet. There is little information regarding the precise neuronal location of 5-HT<sub>2A</sub>R within the ARC. Here, we report that 5-HT<sub>2A</sub>Rs, like 5-HT<sub>2C</sub>Rs (<xref ref-type="bibr" rid="DMM023903C37">Heisler et al., 2002</xref>; <xref ref-type="bibr" rid="DMM023903C49">Lam et al., 2008</xref>), are anatomically positioned to influence the activity of the critical energy balance regulator POMC. The extent to which the activity of POMC neurons can be influenced by action at 5-HT<sub>2A</sub>Rs and whether this mechanism is altered in recuperated offspring as well as direct evidence for linking fetal hyperserotonemia to alteration of 5-HT<sub>2A</sub>R in later life remain to be established.</p>
<p>Because <italic>Htr2a</italic> expression was increased in the ARC of recuperated pups at weaning and in adulthood, but not in brains of fetuses or neonates, the differences in 5-HT<sub>2A</sub>R must be established during the period of catch-up growth, between P3 and P22, much later then the observed differences in 5-HT<sub>2C</sub>R levels. Therefore, upregulation of 5-HT<sub>2A</sub>R might act as a secondary, counter-regulatory response to impaired 5-HT<sub>2C</sub>R signalling. Counter-regulatory mechanisms have been reported among 15 existing 5-HT receptor subtypes as genetic alteration of one specific 5-HT receptor subtype can result in compensatory signalling through another; for example, signalling through 5-HT<sub>1B</sub>R in the absence of 5-HT<sub>2C</sub>R (<xref ref-type="bibr" rid="DMM023903C36">Heisler and Tecott, 2000</xref>; <xref ref-type="bibr" rid="DMM023903C22">Dalton et al., 2004</xref>). It is possible that counter-regulatory upregulation of 5-HT<sub>2A</sub>R in response to impaired signalling through 5-HT<sub>2C</sub>R only emerges when growth-restricted newborn pups are born into and exposed postnatally to an environment of plentiful food. Some effects of early alterations in 5-HT therefore, might only appear in the presence of a particular postnatal environment. This has been shown to be true in a study of 3-month-old infants exposed to a selective serotonin reuptake inhibitor, where altered HPA stress response patterns only became apparent when the method of infant feeding was taken into consideration (<xref ref-type="bibr" rid="DMM023903C62">Oberlander et al., 2008</xref>).</p>
<p>5-HT<sub>2A</sub>R stimulation by administration of agonists produced a greater effect on appetite in recuperated rats, revealing that the overexpressed ARC 5-HT<sub>2A</sub>Rs are functional. As pharmacological stimulation of endogenous 5-HT was less effective in suppressing appetite in recuperated rats, these results suggest that the endogenous circuitry is insufficient to appropriately modulate 5-HT-regulated appetite. However, this change in endogenous programming might be circumvented and the upregulation of the 5-HT<sub>2A</sub>R capitalised upon by pharmacological treatment with a 5-HT<sub>2A</sub>R non-hallucinogenic agonist. The anorectic therapeutic profile could be potentially further improved by combining the 5-HT<sub>2A</sub>R agonist, with 5-HT<sub>2C</sub>R and 5-HT<sub>1B</sub>R agonists, because co-application of 5-HT<sub>2C</sub>R and 5-HT<sub>1B</sub>R agonists produced a significant increase in the activity of POMC in the ARC (<xref ref-type="bibr" rid="DMM023903C24">Doslikova et al., 2013</xref>). Development of a non-hallucinogenic 5-HT<sub>2A</sub>R agonist might seem to be challenging. However, studies showing that the glutamate mGlu2 receptor heterocomplex with 5-HT<sub>2A</sub>R, and not 5-HT<sub>2A</sub>R on its own, acts as a molecular target for the actions of hallucinogenic drugs provide a plausible avenue to explore in the development of therapeutically suitable 5-HT<sub>2A</sub>R agonists (<xref ref-type="bibr" rid="DMM023903C59">Moreno et al., 2011</xref>).</p>
<p>Although we concentrated on studying mechanisms that could mediate the effects of early elevated 5-HT levels on obesity risk in later life, early perturbations in the 5-HT neurotransmitter system are known to have major implications for mental health and behaviour in childhood and adulthood. Increased anxiety-like behaviour in nonhuman primate offspring of dams fed a high-fat diet was associated with perturbations in the 5-HT system during fetal life (<xref ref-type="bibr" rid="DMM023903C80">Sullivan et al., 2010</xref>). Early hyperserotonemia, in particular, has been identified as a potential factor in the pathogenesis of autism spectrum disorder and schizophrenia (<xref ref-type="bibr" rid="DMM023903C18">Chugani, 2004</xref>; <xref ref-type="bibr" rid="DMM023903C52">Madden and Zup, 2014</xref>). In addition, both 5-HT<sub>2A</sub>R and 5-HT<sub>2C</sub>R, which are expressed throughout the brain, have been implicated in the pathophysiology of psychiatric disorders (<xref ref-type="bibr" rid="DMM023903C1">Abramowski et al., 1995</xref>; <xref ref-type="bibr" rid="DMM023903C42">Hoyer et al., 1986</xref>; <xref ref-type="bibr" rid="DMM023903C38">Heisler et al., 2007</xref>; <xref ref-type="bibr" rid="DMM023903C58">Mestre et al., 2013</xref>; <xref ref-type="bibr" rid="DMM023903C51">Lyddon et al., 2013</xref>). 5-HT<sub>2C</sub>R, for example, was shown to play a role in addiction and reward behaviour by modulating dopamine transmission within the mesolimbocortical dopaminergic system (<xref ref-type="bibr" rid="DMM023903C47">Katsidoni et al., 2011</xref>). Dysregulation of the reward-related neurotransmitter systems and behaviours could also contribute to the increased susceptibility to obesity in the recuperated offspring (<xref ref-type="bibr" rid="DMM023903C33">Grissom et al., 2014</xref>).</p>
<p>In summary, we report that elevated 5-HT in fetuses exposed to maternal protein restriction, might underlie a permanent reduction in 5-HT<sub>2C</sub>R expression and function and secondary counter-regulatory upregulation of 5-HT<sub>2A</sub>R and increased sensitivity to 5-HT<sub>2A</sub>R agonists. Thus, our results not only identify a molecular mechanism through which maternal diet might impair offspring energy balance, but also point to a promising pharmacological strategy with 5-HT<sub>2A</sub>R agonist medication to correct this impairment.</p>
</sec>
<sec id="s4" sec-type="methods">
<title>MATERIALS AND METHODS</title>
<sec id="s4a">
<title>Experimental groups and tissue collection</title>
<p>All procedures involving animals were conducted in accordance with the University of Cambridge and the University of Buckingham project licences under the UK Home Office Animals (Scientific Procedures) Act (1986). The breeding of animals was conducted at both the University of Cambridge and the University of Buckingham. Five cohorts of Wistar rats (<italic>Rattus norvegicus</italic>) were established for the studies. One for E16.5 experimental measures, the second for laser-capture microdissection (LCM) and microarray validations, the third for <italic>in situ</italic> hybridisation, the fourth for intracerebroventricular (i3v) and 5-HT/tryptophan measurements and the fifth for protein and mRNA analysis. Detailed information regarding the diet composition and the set-up of the maternal protein restricted and control dams have been published previously (<xref ref-type="bibr" rid="DMM023903C21">Cripps et al., 2009</xref>; <xref ref-type="bibr" rid="DMM023903C5">Berends et al., 2013</xref>). Briefly, on P3, two experimental groups of offspring were established: controls [offspring of control dams (20% protein, w/v), culled to eight (four males and four females) suckled by control dams] and recuperated [offspring of dams fed a low-protein diet (8% protein, w/v) during pregnancy, but nursed by control dams, culled to four males to maximise the plane of nutrition]. The animals were allocated to experimental groups at random. Whole heads were collected from fetuses at E16.5 of pregnancy and from male pups at P3. In addition, hypothalami were dissected from brains of male offspring at P3. The body weight of the remaining pups was recorded at P7, P14 and P21. Following weaning at day 22, one male per litter was culled by a rising concentration of CO<sub>2</sub> and the brain was dissected. After weaning, the remaining males were fed standard laboratory chow and body mass and food intake were recorded weekly. At 3 months, males were culled and brains were collected. All the dissected brains and heads were frozen on powdered dry ice and were stored at −80°C until further processing. Amniotic fluid and placentas were harvested at E16.5 and serum was prepared from the dams and male pups at P3, weaning and 3 months, and stored at −80°C prior to the measurement of 5HT and tryptophan levels.</p>
</sec>
<sec id="s4b">
<title>5-HT and tryptophan assay</title>
<p>Whole brains, placentas, amniotic fluid and serum were used for measurement of 5-HT (DRG International) and tryptophan (Abnova) by ELISA, following the manufacturer's recommendation for sample preparation, acylation (5-HT) and derivatisation (tryptophan). For the measurement of 5-HT in tissue, hypothalamic blocks were excised from frozen brains and extracted as described (<xref ref-type="bibr" rid="DMM023903C43">Huang et al., 2012</xref>). Briefly, samples were homogenised and deproteinised for 30 min in 0.2 N perchloric acid solution containing 7.9 mM Na<sub>2</sub>S<sub>2</sub>O<sub>5</sub> and 1.3 mM disodium ethyleneamine-tetra-acetic acid. The homogenate was centrifuged at 10,000 <bold><italic>g</italic></bold> for 10 min at 4°C and the supernatant assayed for 5-HT.</p>
</sec>
<sec id="s4c">
<title>Feeding studies</title>
<p>Animals were cannulated as described previously (<xref ref-type="bibr" rid="DMM023903C79">Stocker et al., 2012</xref>). Briefly, a cannula was inserted into the third ventricle under a gaseous anaesthetic (isofluorane: Isoba, Schering-Plough Animal Health) using coordinates from the stereotactic rat brain atlas (<xref ref-type="bibr" rid="DMM023903C65">Paxinos and Watson, 1998</xref>). Its position was verified by a positive drinking response over 15 min to angiotensin II (20 µg ml<sup>−1</sup> in 2.5 µl). For measurements of acute effects of D-fenfluramine or 5-HT<sub>2A</sub>R agonism on food intake, 3-month-old rats were individually housed, fasted for 4 h, dosed at the beginning of the 12 h dark period and re-fed. Peptide (250 nmol) was given in 2.5 µl saline. Animals were dosed using a Latin square design. Doses were separated by at least 4 days and normal feeding behaviour and body mass was restored prior to administration of the next dose. The specificity and doses of the D-fenfluramine (Tocris Bioscience), or the high-affinity 5-HT<sub>2A</sub>R receptor agonist TCB2 (Tocris Bioscience) were based on published data (<xref ref-type="bibr" rid="DMM023903C86">Vickers et al., 1999</xref><xref ref-type="bibr" rid="DMM023903C87">, 2001</xref>; <xref ref-type="bibr" rid="DMM023903C85">Trifunovic and Reilly, 2006</xref>; <xref ref-type="bibr" rid="DMM023903C57">McLean et al., 2006</xref>; <xref ref-type="bibr" rid="DMM023903C92">Xu et al., 2010</xref>; <xref ref-type="bibr" rid="DMM023903C27">Fox et al., 2010</xref>) and doses were optimised.</p>
</sec>
<sec id="s4d">
<title>Western blotting</title>
<p>Hypothalami were dissected from frozen brains according to landmarks: anterior to the optic chiasma, posterior to the mammillary bodies, lateral at the hypothalamic sulcus and superior to the anterior commissure. Dissected hypothalami from P3 and 3-month-old male offspring were homogenised in TK lysis buffer and western blotting analysis was carried out as previously described (<xref ref-type="bibr" rid="DMM023903C56">Martin-Gronert et al., 2008</xref>). Anti-goat primary antibody against 5-HT<sub>2C</sub>R purchased from Santa Cruz Biotechnology (sc-15081, lot D1114) was used at 1:200 dilution. The antibody was validated in two previous studies (<xref ref-type="bibr" rid="DMM023903C14">Bubar et al., 2005</xref>; <xref ref-type="bibr" rid="DMM023903C4">Anastasio et al., 2010</xref>). Anti-goat horseradish peroxidase-conjugated secondary antibody (Jackson ImmunoResearch) was used at 1:10,000 dilution.</p>
</sec>
<sec id="s4e">
<title>Laser-capture microdissection, RNA isolation and analysis</title>
<p>Hypothalamic sections of the ARC were prepared on a cryostat at 14 µm thickness from approximately −4.52 to −2.30 mm relative to Bregma (<xref ref-type="bibr" rid="DMM023903C65">Paxinos and Watson, 1998</xref>). Sections were collected onto RNase-free membrane-coated slides (PALM Microlaser Technologies) that had been baked at 200°C for 4 h and UV cross-linked for 30 min. Within 24 h of sectioning, sections were placed for 30 s each time in 95%, 75% and 50% ethanol for rehydration. Sections were stained with 1% Cresyl Violet stain (Ambion) for 1 min, dehydrated in graded ethanol concentrations (50%, 75% and twice in 100% for 30 s each time), placed in HistoClear (National Diagnostics) for 5 min and air dried. LCM was performed using a PALM MicrolaserSystem (<xref ref-type="fig" rid="DMM023903F4">Fig. 4</xref>A). Following microdissection, the captured cells were kept in RNAlater (Ambion). Total RNA was isolated from LCM samples using the RNAqueous Micro RNA extraction kit (Ambion) in accordance with the manufacturer's protocol. The quality and quantity of the RNA samples was determined using Agilent BioAnalyzer PicoChips (Agilent Technologies). Total RNA was isolated from E16.5 fetal heads and neonatal and adult (3 months of age) hypothalami as previously described (<xref ref-type="bibr" rid="DMM023903C95">Zaibi et al., 2010</xref>) and analysed using a NanoDrop ND1000 (Thermo Fisher Scientific).</p>
</sec>
<sec id="s4f">
<title>RNA amplification</title>
<p>An ovation Pico RNA Amplification System (Nugen Technologies) was used for the amplification of RNA destined for microarray analysis. RNA amplification of LCM ARC samples used to validate genes identified by microarray analysis was performed using a MegaScript T7 Amplification Kit (Ambion) in combination with the GeneChip sample CleanUp Module kit (Affymetrix). The use of a different method of RNA amplification enhanced the validation of the microarray data.</p>
</sec>
<sec id="s4g">
<title>Microarray hybridisation</title>
<p>The amplified RNA was used for gene expression profiling on Affymetrix Rat Genome 230 2.0 Arrays (Affymetrix) using the Affymetrix GeneChip protocol to fragment and label the target, ready for hybridisation to the arrays (Affymetrix 2004). GeneChip sequences were selected from GenBank, dbEST and RefSeq and the sequence clusters created using UniGene were then further refined by comparison with the publicly available assembly of the rat genome. Microarray hybridisation was carried out by Molecular Biology Services at the University of Warwick, using <italic>n</italic>=6 chips per group.</p>
</sec>
<sec id="s4h">
<title>Microarray analysis and selection of the genes for validation</title>
<p>Raw image data files were converted to CEL and pivot files using Affymetrix GeneChip Operating Software. All downstream analysis of microarray data was performed using GeneSpring GX 12.0 (Agilent). The CEL files were used for the RMA (<xref ref-type="bibr" rid="DMM023903C44">Irizarry et al., 2003</xref>) and GC-RMA (<xref ref-type="bibr" rid="DMM023903C90">Wu et al., 2004</xref>) analyses, whereas the pivot files were used for GCOS analysis. After importing the data, each chip was normalised to the 50th centile of the measurement taken from that chip and all gene expression data reported as a fold-change from the control state. Genes were considered to be up- or downregulated if the 1.3-fold threshold was reached and <italic>P</italic>&lt;0.05. Only genes that met the above criteria using three different algorithms: GCOS, RMA and GCRMA were taken forward for additional study. The further selection of genes for validation was based on the function of the gene and the availability of suitable primers for validation. Functional analysis was performed using Ingenuity Pathway Analysis (Ingenuity Systems).</p>
</sec>
<sec id="s4i">
<title>Validation of microarray data using Taqman RT-PCR</title>
<p>Validation of the microarray data was carried out using Micro Fluidic Cards (Applied Biosystems) in accordance with the manufacturer's protocol. The reactions were performed in duplicate for each sample using an ABI 7900HT (Applied Biosystems). A standard curve was constructed for each gene using a serial dilution of pooled cDNA from all LCM ARC samples. The mean C<sub>T</sub> values of the experimental samples were then used to calculate the relative expression for each sample. The data was normalised to <italic>Ppia</italic> (cyclophilin) expression, which did not change between maternal treatment groups. Real-time PCR (StepOne, Applied Biosystems) was carried out using Assay-on-Demand pre-designed primer and probe sets (Applied Biosystems). Data were analysed using the comparative ΔC<sub>T</sub> method, comparing recuperated animals with controls. All procedures were carried out in accordance with the manufacturer's recommendation.</p>
</sec>
<sec id="s4j">
<title><italic>In situ</italic> hybridisation histochemistry</title>
<p>Coronal sections (20 µm) of frozen hypothalamic ARC, obtained using a cryostat, were thaw-mounted onto poly-L-lysine slides (Polysine, Menzel Glaser, Braunschweig, Germany). Ten sets of slides per animal were serially collected, with the first set of 10 beginning at approximately −4.52 and ending at −2.12 mm, relative to Bregma, according to the atlas of the rat brain (Paxinos and Watson, 1998). For the sectioning of neonatal rat brains, whole heads were used and the sectioning was guided by the neonatal rat brain atlas (<xref ref-type="bibr" rid="DMM023903C70">Ramachandra and Subramanian, 2011</xref>). Slides were stored at −80°C until use.</p>
<p>A [<sup>35</sup>S]-radiolabelled riboprobe targeting nucleotides 1700-1910 of the rat <italic>Htr2a</italic> mRNA transcript was generated by PCR from whole rat brain cDNA. The 210 bp fragment was cloned into pCR-TOPO4 (Life Technologies). For antisense probe generation, <italic>Pst</italic>I linearised recombinant plasmid was subjected to <italic>in vitro</italic> transcription using T7 polymerase in the presence of <sup>35</sup>S-labelled UTP, as per the manufacturer's instructions (Ambion). The ISHH procedure used has been described in detail previously (<xref ref-type="bibr" rid="DMM023903C3">Alon et al., 2009</xref>; <xref ref-type="bibr" rid="DMM023903C29">Garfield et al., 2012</xref>). Autoradiographic images were quantified using Image Proplus software (Media Cybernetics). Standard curves were generated from <sup>14</sup>C autoradiographic microscales (Amersham) and integrated optical density (IOD) and area of the hybridisation signal were measured. For each animal, 3-5 sections of ARC (−4.52 mm to −2.12 mm from Bregma) and 2-3 sections for VMN (−3.60 mm to −2.12 mm from Bregma) were analysed. Average ARC and VMH <italic>Htr2a</italic> mRNA expression was calculated.</p>
</sec>
<sec id="s4k">
<title>Dual-label ISHH and immunohistochemistry</title>
<p>To assess colocalisation of 5-HT<sub>2A</sub>R and POMC, brains taken from control rats, were first processed for detection of <italic>Htr2a</italic> mRNA by ISHH, as described above. Following this, the tissue was washed in PBS before commencement of the IHC protocol to label α-melanocyte-stimulating hormone (α-MSH) protein using procedures previously described (<xref ref-type="bibr" rid="DMM023903C3">Alon et al., 2009</xref>; <xref ref-type="bibr" rid="DMM023903C29">Garfield et al., 2012</xref>). Briefly, sections were incubated in 0.3% H<sub>2</sub>O<sub>2</sub> in PBS, then rinsed in PBS, blocked in 0.5% BSA/0.5% Triton X-100 in PBS and left in blocking buffer containing rabbit α-MSH antibody (1/10,000; Chemicon, Millipore, MA, USA) overnight. Tissue was then washed in PBS and a biotinylated donkey anti-rabbit secondary antibody (Vector Laboratories) was applied at 1:1000 in blocking buffer. Sections were then washed in PBS, incubated in VectaStain ABC reagent, and following this, chromogenic detection was conducted using 3,3′-diaminobenzidine (DAB) reagent (Vector Laboratories). Sections were mounted onto superfrost slides, dried, then dipped in photographic emulsion (Kodak) and stored at 4°C for 2 weeks before being developed using Kodak developer and fixer. Double-labelled cells were recorded if α-MSH-immunoreactive (IR) cell bodies were overlaid with a [<sup>35</sup>S]<italic>Htr2a</italic> signal greater than 3× background.</p>
</sec>
<sec id="s4l">
<title>Statistical analysis</title>
<p>Two-tailed unpaired Student's <italic>t</italic>-test was used for statistical analysis and the data are presented as means±s.e.m. unless otherwise stated. Fractional growth rates were calculated using formula: fractional growth rate=(current−starting mass)/(period×starting mass). For microarray data <italic>P</italic>-values were calculated using a two-tailed <italic>t</italic>-test. All data were analysed using GraphPad Prism. Number (<italic>n</italic>) refers to number of litters used. <italic>P</italic>&lt;0.05 was considered statistically significant.</p>
</sec>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>We thank Adrian Wayman for technical assistance. Microarray hybridisation was carried out by Molecular Biology Services at the University of Warwick.</p>
</ack>
<fn-group>
<title>Footnotes</title>
<fn fn-type="conflict">
<p>
<bold>Competing interests</bold>
</p>
<p>The authors declare no competing or financial interests.</p>
</fn>
<fn>
<p>
<bold>Author contributions</bold>
</p>
<p>M.S.M.-G., C.J.S., E.T.W., R.L.C., M.A.C., J.R.S.A., G.S.H.Y., L.K.H. and S.E.O. contributed to the conception, design and interpretation of the data. M.S.M.-G., C.J.S., E.T.W., R.L.C., A.S.G., Z.J., G.D. and G.S.H.Y. helped acquire the data. M.S.M.-G., C.J.S., E.T.W. and Z.J. analysed the data. M.S.M.-G., L.K.H. and S.E.O. wrote the manuscript. All authors have revised the final version of the manuscript.</p>
</fn>
<fn fn-type="financial-disclosure">
<p>
<bold>Funding</bold>
</p>
<p>This research was supported by the Biotechnology and Biological Sciences Research Council [E007821/1 to M.S.M.-G., R.L.C. and E00797X/1; BB/K001418 /1 to L.K.H.]; the British Heart Foundation [FS/09/029/27902 to S.E.O.]; the UK Medical Research Council Metabolic Diseases Unit [MC_UU_12012/4 to S.E.O. and MC_UU_12012/1 to G.S.H.Y.]; the Wellcome Trust [WT081713 and WT098012 to L.K.H.]; the European Union [FP7-HEALTH-266408 Full4Health to G.S.H.Y.]; and the Helmholtz Alliance ICEMED to G.S.H.Y.</p>
</fn>
</fn-group>
<sec id="s5">
<title>Data availability</title>
<p>Data have been deposited in Gene Expression Omnibus (accession number GSE76012) at <uri xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE76012">http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE76012</uri>.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="DMM023903C1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abramowski</surname><given-names>D.</given-names></name>, <name><surname>Rigo</surname><given-names>M.</given-names></name>, <name><surname>Duc</surname><given-names>D.</given-names></name>, <name><surname>Hoyer</surname><given-names>D.</given-names></name> and <name><surname>Staufenbiel</surname><given-names>M.</given-names></name></person-group> (<year>1995</year>). <article-title>Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera</article-title>. <source/><italic>Neuropharmacology</italic>
<volume>34</volume>, <fpage>1635</fpage>-<lpage>1645</lpage>. <pub-id pub-id-type="doi">10.1016/0028-3908(95)00138-7</pub-id><pub-id pub-id-type="pmid">8788961</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aitken</surname><given-names>A. R.</given-names></name> and <name><surname>Tork</surname><given-names>I.</given-names></name></person-group> (<year>1988</year>). <article-title>Early development of serotonin-containing neurons and pathways as seen in wholemount preparations of the fetal rat brain</article-title>. <source/><italic>J. Comp. Neurol.</italic>
<volume>274</volume>, <fpage>32</fpage>-<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1002/cne.902740105</pub-id><pub-id pub-id-type="pmid">3047187</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alon</surname><given-names>T.</given-names></name>, <name><surname>Zhou</surname><given-names>L.</given-names></name>, <name><surname>Pérez</surname><given-names>C. A.</given-names></name>, <name><surname>Garfield</surname><given-names>A. S.</given-names></name>, <name><surname>Friedman</surname><given-names>J. M.</given-names></name> and <name><surname>Heisler</surname><given-names>L. K.</given-names></name></person-group> (<year>2009</year>). <article-title>Transgenic mice expressing green fluorescent protein under the control of the corticotropin-releasing hormone promoter</article-title>. <source/><italic>Endocrinology</italic>
<volume>150</volume>, <fpage>5626</fpage>-<lpage>5632</lpage>. <pub-id pub-id-type="doi">10.1210/en.2009-0881</pub-id><pub-id pub-id-type="pmid">19854866</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anastasio</surname><given-names>N. C.</given-names></name>, <name><surname>Lanfranco</surname><given-names>M. F.</given-names></name>, <name><surname>Bubar</surname><given-names>M. J.</given-names></name>, <name><surname>Seitz</surname><given-names>P. K.</given-names></name>, <name><surname>Stutz</surname><given-names>S. J.</given-names></name>, <name><surname>McGinnis</surname><given-names>A. G.</given-names></name>, <name><surname>Watson</surname><given-names>C. S.</given-names></name> and <name><surname>Cunningham</surname><given-names>K. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Serotonin 5-HT2C receptor protein expression is enriched in synaptosomal and post-synaptic compartments of rat cortex</article-title>. <source/><italic>J. Neurochem.</italic>
<volume>113</volume>, <fpage>1504</fpage>-<lpage>1515</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2010.06694.x</pub-id><pub-id pub-id-type="pmid">20345755</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berends</surname><given-names>L. M.</given-names></name>, <name><surname>Fernandez-Twinn</surname><given-names>D. S.</given-names></name>, <name><surname>Martin-Gronert</surname><given-names>M. S.</given-names></name>, <name><surname>Cripps</surname><given-names>R. L.</given-names></name> and <name><surname>Ozanne</surname><given-names>S. E.</given-names></name></person-group> (<year>2013</year>). <article-title>Catch-up growth following intra-uterine growth-restriction programmes an insulin-resistant phenotype in adipose tissue</article-title>. <source/><italic>Int. J. Obes.</italic>
<volume>37</volume>, <fpage>1051</fpage>-<lpage>1057</lpage>. <pub-id pub-id-type="doi">10.1038/ijo.2012.196</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berg</surname><given-names>C.</given-names></name>, <name><surname>Backström</surname><given-names>T.</given-names></name>, <name><surname>Winberg</surname><given-names>S.</given-names></name>, <name><surname>Lindberg</surname><given-names>R.</given-names></name> and <name><surname>Brandt</surname><given-names>I.</given-names></name></person-group> (<year>2013</year>). <article-title>Developmental exposure to fluoxetine modulates the serotonin system in hypothalamus</article-title>. <source/><italic>PLoS ONE</italic>
<volume>8</volume>, <fpage>e55053</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0055053</pub-id><pub-id pub-id-type="pmid">23383055</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berglund</surname><given-names>E. D.</given-names></name>, <name><surname>Liu</surname><given-names>C.</given-names></name>, <name><surname>Sohn</surname><given-names>J.-W.</given-names></name>, <name><surname>Liu</surname><given-names>T.</given-names></name>, <name><surname>Kim</surname><given-names>M. H.</given-names></name>, <name><surname>Lee</surname><given-names>C. E.</given-names></name>, <name><surname>Vianna</surname><given-names>C. R.</given-names></name>, <name><surname>Williams</surname><given-names>K. W.</given-names></name>, <name><surname>Xu</surname><given-names>Y.</given-names></name> and <name><surname>Elmquist</surname><given-names>J. K.</given-names></name></person-group> (<year>2013</year>). <article-title>Serotonin 2C receptors in pro-opiomelanocortin neurons regulate energy and glucose homeostasis</article-title>. <source/><italic>J. Clin. Invest.</italic>
<volume>123</volume>, <fpage>5061</fpage>-<lpage>5070</lpage>. <pub-id pub-id-type="doi">10.1172/JCI70338</pub-id><pub-id pub-id-type="pmid">24177424</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bieswal</surname><given-names>F.</given-names></name>, <name><surname>Ahn</surname><given-names>M.-T.</given-names></name>, <name><surname>Reusens</surname><given-names>B.</given-names></name>, <name><surname>Holvoet</surname><given-names>P.</given-names></name>, <name><surname>Raes</surname><given-names>M.</given-names></name>, <name><surname>Rees</surname><given-names>W. D.</given-names></name> and <name><surname>Remacle</surname><given-names>C.</given-names></name></person-group> (<year>2006</year>). <article-title>The importance of catch-up growth after early malnutrition for the programming of obesity in male rat</article-title>. <source/><italic>Obesity</italic>
<volume>14</volume>, <fpage>1330</fpage>-<lpage>1343</lpage>. <pub-id pub-id-type="doi">10.1038/oby.2006.151</pub-id><pub-id pub-id-type="pmid">16988075</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonnin</surname><given-names>A.</given-names></name> and <name><surname>Levitt</surname><given-names>P.</given-names></name></person-group> (<year>2011</year>). <article-title>Fetal, maternal, and placental sources of serotonin and new implications for developmental programming of the brain</article-title>. <source/><italic>Neuroscience</italic>
<volume>197</volume>, <fpage>1</fpage>-<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2011.10.005</pub-id><pub-id pub-id-type="pmid">22001683</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonnin</surname><given-names>A.</given-names></name>, <name><surname>Goeden</surname><given-names>N.</given-names></name>, <name><surname>Chen</surname><given-names>K.</given-names></name>, <name><surname>Wilson</surname><given-names>M. L.</given-names></name>, <name><surname>King</surname><given-names>J.</given-names></name>, <name><surname>Shih</surname><given-names>J. C.</given-names></name>, <name><surname>Blakely</surname><given-names>R. D.</given-names></name>, <name><surname>Deneris</surname><given-names>E. S.</given-names></name> and <name><surname>Levitt</surname><given-names>P.</given-names></name></person-group> (<year>2011</year>). <article-title>A transient placental source of serotonin for the fetal forebrain</article-title>. <source/><italic>Nature</italic>
<volume>472</volume>, <fpage>347</fpage>-<lpage>350</lpage>. <pub-id pub-id-type="doi">10.1038/nature09972</pub-id><pub-id pub-id-type="pmid">21512572</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouret</surname><given-names>S. G.</given-names></name></person-group> (<year>2010</year>). <article-title>Leptin, nutrition, and the programming of hypothalamic feeding circuits</article-title>. <source/><italic>Nestle Nutr. Workshop Ser. Pediatr. Prog.</italic>
<volume>65</volume>, <fpage>25</fpage>-<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1159/000281143</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouret</surname><given-names>S. G.</given-names></name>, <name><surname>Draper</surname><given-names>S. J.</given-names></name> and <name><surname>Simerly</surname><given-names>R. B.</given-names></name></person-group> (<year>2004</year>). <article-title>Trophic action of leptin on hypothalamic neurons that regulate feeding</article-title>. <source/><italic>Science</italic>
<volume>304</volume>, <fpage>108</fpage>-<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1126/science.1095004</pub-id><pub-id pub-id-type="pmid">15064420</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broad</surname><given-names>K. D.</given-names></name> and <name><surname>Keverne</surname><given-names>E. B.</given-names></name></person-group> (<year>2011</year>). <article-title>Placental protection of the fetal brain during short-term food deprivation</article-title>. <source/><italic>Proc. Natl. Acad. Sci. USA</italic>
<volume>108</volume>, <fpage>15237</fpage>-<lpage>15241</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1106022108</pub-id><pub-id pub-id-type="pmid">21810990</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bubar</surname><given-names>M. J.</given-names></name>, <name><surname>Seitz</surname><given-names>P. K.</given-names></name>, <name><surname>Thomas</surname><given-names>M. L.</given-names></name> and <name><surname>Cunningham</surname><given-names>K. A.</given-names></name></person-group> (<year>2005</year>). <article-title>Validation of a selective serotonin 5-HT(2C) receptor antibody for utilization in fluorescence immunohistochemistry studies</article-title>. <source/><italic>Brain Res.</italic>
<volume>1063</volume>, <fpage>105</fpage>-<lpage>113</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2005.09.050</pub-id><pub-id pub-id-type="pmid">16274677</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burke</surname><given-names>L. K.</given-names></name>, <name><surname>Doslikova</surname><given-names>B.</given-names></name>, <name><surname>D'Agostino</surname><given-names>G.</given-names></name>, <name><surname>Garfield</surname><given-names>A. S.</given-names></name>, <name><surname>Farooq</surname><given-names>G.</given-names></name>, <name><surname>Burdakov</surname><given-names>D.</given-names></name>, <name><surname>Low</surname><given-names>M. J.</given-names></name>, <name><surname>Rubinstein</surname><given-names>M.</given-names></name>, <name><surname>Evans</surname><given-names>M. L.</given-names></name>, <name><surname>Billups</surname><given-names>B.</given-names></name><etal>et al.</etal></person-group> (<year>2014</year>). <article-title>5-HT obesity medication efficacy via POMC activation is maintained during aging</article-title>. <source/><italic>Endocrinology</italic>
<volume>155</volume>, <fpage>3732</fpage>-<lpage>3738</lpage>. <pub-id pub-id-type="doi">10.1210/en.2014-1223</pub-id><pub-id pub-id-type="pmid">25051442</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carr</surname><given-names>K. A.</given-names></name>, <name><surname>Lin</surname><given-names>H.</given-names></name>, <name><surname>Fletcher</surname><given-names>K. D.</given-names></name>, <name><surname>Sucheston</surname><given-names>L.</given-names></name>, <name><surname>Singh</surname><given-names>P. K.</given-names></name>, <name><surname>Salis</surname><given-names>R. J.</given-names></name>, <name><surname>Erbe</surname><given-names>R. W.</given-names></name>, <name><surname>Faith</surname><given-names>M. S.</given-names></name>, <name><surname>Allison</surname><given-names>D. B.</given-names></name>, <name><surname>Stice</surname><given-names>E.</given-names></name><etal>et al.</etal></person-group> (<year>2013</year>). <article-title>Two functional serotonin polymorphisms moderate the effect of food reinforcement on BMI</article-title>. <source/><italic>Behav. Neurosci.</italic>
<volume>127</volume>, <fpage>387</fpage>-<lpage>399</lpage>. <pub-id pub-id-type="doi">10.1037/a0032026</pub-id><pub-id pub-id-type="pmid">23544600</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chugani</surname><given-names>D. C.</given-names></name></person-group> (<year>2004</year>). <article-title>Serotonin in autism and pediatric epilepsies</article-title>. <source/><italic>Ment. Retard. Dev. Disabil. Res. Rev.</italic>
<volume>10</volume>, <fpage>112</fpage>-<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1002/mrdd.20021</pub-id><pub-id pub-id-type="pmid">15362166</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cote</surname><given-names>F.</given-names></name>, <name><surname>Fligny</surname><given-names>C.</given-names></name>, <name><surname>Bayard</surname><given-names>E.</given-names></name>, <name><surname>Launay</surname><given-names>J.-M.</given-names></name>, <name><surname>Gershon</surname><given-names>M. D.</given-names></name>, <name><surname>Mallet</surname><given-names>J.</given-names></name> and <name><surname>Vodjdani</surname><given-names>G.</given-names></name></person-group> (<year>2007</year>). <article-title>Maternal serotonin is crucial for murine embryonic development</article-title>. <source/><italic>Proc. Natl. Acad. Sci. USA</italic>
<volume>104</volume>, <fpage>329</fpage>-<lpage>334</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0606722104</pub-id><pub-id pub-id-type="pmid">17182745</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cottrell</surname><given-names>E. C.</given-names></name>, <name><surname>Martin-Gronert</surname><given-names>M. S.</given-names></name>, <name><surname>Fernandez-Twinn</surname><given-names>D. S.</given-names></name>, <name><surname>Luan</surname><given-names>J.</given-names></name>, <name><surname>Berends</surname><given-names>L. M.</given-names></name> and <name><surname>Ozanne</surname><given-names>S. E.</given-names></name></person-group> (<year>2011</year>). <article-title>Leptin-independent programming of adult body weight and adiposity in mice</article-title>. <source/><italic>Endocrinology</italic>
<volume>152</volume>, <fpage>476</fpage>-<lpage>482</lpage>. <pub-id pub-id-type="doi">10.1210/en.2010-0911</pub-id><pub-id pub-id-type="pmid">21209019</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cripps</surname><given-names>R. L.</given-names></name>, <name><surname>Martin-Gronert</surname><given-names>M. S.</given-names></name>, <name><surname>Archer</surname><given-names>Z. A.</given-names></name>, <name><surname>Hales</surname><given-names>C. N.</given-names></name>, <name><surname>Mercer</surname><given-names>J. G.</given-names></name> and <name><surname>Ozanne</surname><given-names>S. E.</given-names></name></person-group> (<year>2009</year>). <article-title>Programming of hypothalamic neuropeptide gene expression in rats by maternal dietary protein content during pregnancy and lactation</article-title>. <source/><italic>Clin. Sci.</italic>
<volume>117</volume>, <fpage>85</fpage>-<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1042/CS20080393</pub-id><pub-id pub-id-type="pmid">19152506</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalton</surname><given-names>G. L.</given-names></name>, <name><surname>Lee</surname><given-names>M. D.</given-names></name>, <name><surname>Kennett</surname><given-names>G. A.</given-names></name>, <name><surname>Dourish</surname><given-names>C. T.</given-names></name> and <name><surname>Clifton</surname><given-names>P. G.</given-names></name></person-group> (<year>2004</year>). <article-title>mCPP-induced hyperactivity in 5-HT2C receptor mutant mice is mediated by activation of multiple 5-HT receptor subtypes</article-title>. <source/><italic>Neuropharmacology</italic>
<volume>46</volume>, <fpage>663</fpage>-<lpage>671</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2003.11.012</pub-id><pub-id pub-id-type="pmid">14996544</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Fanti</surname><given-names>B. A.</given-names></name>, <name><surname>Hamilton</surname><given-names>J. S.</given-names></name> and <name><surname>Horwitz</surname><given-names>B. A.</given-names></name></person-group> (<year>2001</year>). <article-title>Meal-induced changes in extracellular 5-HT in medial hypothalamus of lean (Fa/Fa) and obese (fa/fa) Zucker rats</article-title>. <source/><italic>Brain Res.</italic>
<volume>902</volume>, <fpage>164</fpage>-<lpage>170</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-8993(01)02371-X</pub-id><pub-id pub-id-type="pmid">11384609</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doslikova</surname><given-names>B.</given-names></name>, <name><surname>Garfield</surname><given-names>A. S.</given-names></name>, <name><surname>Shaw</surname><given-names>J.</given-names></name>, <name><surname>Evans</surname><given-names>M. L.</given-names></name>, <name><surname>Burdakov</surname><given-names>D.</given-names></name>, <name><surname>Billups</surname><given-names>B.</given-names></name> and <name><surname>Heisler</surname><given-names>L. K.</given-names></name></person-group> (<year>2013</year>). <article-title>5-HT2C receptor agonist anorectic efficacy potentiated by 5-HT1B receptor agonist coapplication: an effect mediated via increased proportion of pro-opiomelanocortin neurons activated</article-title>. <source/><italic>J. Neurosci.</italic>
<volume>33</volume>, <fpage>9800</fpage>-<lpage>9804</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4326-12.2013</pub-id><pub-id pub-id-type="pmid">23739976</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erritzoe</surname><given-names>D.</given-names></name>, <name><surname>Frokjaer</surname><given-names>V. G.</given-names></name>, <name><surname>Haugbol</surname><given-names>S.</given-names></name>, <name><surname>Marner</surname><given-names>L.</given-names></name>, <name><surname>Svarer</surname><given-names>C.</given-names></name>, <name><surname>Holst</surname><given-names>K.</given-names></name>, <name><surname>Baaré</surname><given-names>W. F. C.</given-names></name>, <name><surname>Rasmussen</surname><given-names>P. M.</given-names></name>, <name><surname>Madsen</surname><given-names>J.</given-names></name>, <name><surname>Paulson</surname><given-names>O. B.</given-names></name><etal>et al.</etal></person-group> (<year>2009</year>). <article-title>Brain serotonin 2A receptor binding: relations to body mass index, tobacco and alcohol use</article-title>. <source/><italic>Neuroimage</italic>
<volume>46</volume>, <fpage>23</fpage>-<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2009.01.050</pub-id><pub-id pub-id-type="pmid">19457377</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez-Twinn</surname><given-names>D. S.</given-names></name>, <name><surname>Ozanne</surname><given-names>S. E.</given-names></name>, <name><surname>Ekizoglou</surname><given-names>S.</given-names></name>, <name><surname>Doherty</surname><given-names>C.</given-names></name>, <name><surname>James</surname><given-names>L.</given-names></name>, <name><surname>Gusterson</surname><given-names>B.</given-names></name> and <name><surname>Hales</surname><given-names>C. N.</given-names></name></person-group> (<year>2003</year>). <article-title>The maternal endocrine environment in the low-protein model of intra-uterine growth restriction</article-title>. <source/><italic>Br. J. Nutr.</italic>
<volume>90</volume>, <fpage>815</fpage>-<lpage>822</lpage>. <pub-id pub-id-type="doi">10.1079/BJN2003967</pub-id><pub-id pub-id-type="pmid">13129451</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>M. A.</given-names></name>, <name><surname>French</surname><given-names>H. T.</given-names></name>, <name><surname>LaPorte</surname><given-names>J. L.</given-names></name>, <name><surname>Blackler</surname><given-names>A. R.</given-names></name> and <name><surname>Murphy</surname><given-names>D. L.</given-names></name></person-group> (<year>2010</year>). <article-title>The serotonin 5-HT(2A) receptor agonist TCB-2: a behavioral and neurophysiological analysis</article-title>. <source/><italic>Psychopharmacology</italic>
<volume>212</volume>, <fpage>13</fpage>-<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-009-1694-1</pub-id><pub-id pub-id-type="pmid">19823806</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukagawa</surname><given-names>N. K.</given-names></name>, <name><surname>Minaker</surname><given-names>K. L.</given-names></name>, <name><surname>Rowe</surname><given-names>J. W.</given-names></name> and <name><surname>Young</surname><given-names>V. R.</given-names></name></person-group> (<year>1987</year>). <article-title>Plasma tryptophan and total neutral amino acid levels in men: influence of hyperinsulinemia and age</article-title>. <source/><italic>Metabolism</italic>
<volume>36</volume>, <fpage>683</fpage>-<lpage>686</lpage>. <pub-id pub-id-type="doi">10.1016/0026-0495(87)90154-5</pub-id><pub-id pub-id-type="pmid">3600282</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garfield</surname><given-names>A. S.</given-names></name>, <name><surname>Patterson</surname><given-names>C.</given-names></name>, <name><surname>Skora</surname><given-names>S.</given-names></name>, <name><surname>Gribble</surname><given-names>F. M.</given-names></name>, <name><surname>Reimann</surname><given-names>F.</given-names></name>, <name><surname>Evans</surname><given-names>M. L.</given-names></name>, <name><surname>Myers</surname><given-names>M. G.</given-names><suffix>Jr</suffix></name> and <name><surname>Heisler</surname><given-names>L. K.</given-names></name></person-group> (<year>2012</year>). <article-title>Neurochemical characterization of body weight-regulating leptin receptor neurons in the nucleus of the solitary tract</article-title>. <source/><italic>Endocrinology</italic>
<volume>153</volume>, <fpage>4600</fpage>-<lpage>4607</lpage>. <pub-id pub-id-type="doi">10.1210/en.2012-1282</pub-id><pub-id pub-id-type="pmid">22869346</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaspar</surname><given-names>P.</given-names></name>, <name><surname>Cases</surname><given-names>O.</given-names></name> and <name><surname>Maroteaux</surname><given-names>L.</given-names></name></person-group> (<year>2003</year>). <article-title>The developmental role of serotonin: news from mouse molecular genetics</article-title>. <source/><italic>Nat. Rev. Neurosci.</italic>
<volume>4</volume>, <fpage>1002</fpage>
<pub-id pub-id-type="doi">10.1038/nrn1256</pub-id><pub-id pub-id-type="pmid">14618156</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gherzi</surname><given-names>R.</given-names></name>, <name><surname>Trabucchi</surname><given-names>M.</given-names></name>, <name><surname>Ponassi</surname><given-names>M.</given-names></name>, <name><surname>Ruggiero</surname><given-names>T.</given-names></name>, <name><surname>Corte</surname><given-names>G.</given-names></name>, <name><surname>Moroni</surname><given-names>C.</given-names></name>, <name><surname>Chen</surname><given-names>C.-Y.</given-names></name>, <name><surname>Khabar</surname><given-names>K. S.</given-names></name>, <name><surname>Andersen</surname><given-names>J. S.</given-names></name> and <name><surname>Briata</surname><given-names>P.</given-names></name></person-group> (<year>2006</year>). <article-title>The RNA-binding protein KSRP promotes decay of beta-catenin mRNA and is inactivated by PI3K-AKT signaling</article-title>. <source/><italic>PLoS Biol.</italic>
<volume>5</volume>, <fpage>e5</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pbio.0050005</pub-id><pub-id pub-id-type="pmid">17177604</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glavas</surname><given-names>M. M.</given-names></name>, <name><surname>Joachim</surname><given-names>S. E.</given-names></name>, <name><surname>Draper</surname><given-names>S. J.</given-names></name>, <name><surname>Smith</surname><given-names>M. S.</given-names></name> and <name><surname>Grove</surname><given-names>K. L.</given-names></name></person-group> (<year>2007</year>). <article-title>Melanocortinergic activation by melanotan II inhibits feeding and increases uncoupling protein 1 messenger ribonucleic acid in the developing rat</article-title>. <source/><italic>Endocrinology</italic>
<volume>148</volume>, <fpage>3279</fpage>-<lpage>3287</lpage>. <pub-id pub-id-type="doi">10.1210/en.2007-0184</pub-id><pub-id pub-id-type="pmid">17412803</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grissom</surname><given-names>N.</given-names></name>, <name><surname>Bowman</surname><given-names>N.</given-names></name> and <name><surname>Reyes</surname><given-names>T. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Epigenetic programming of reward function in offspring: a role for maternal diet</article-title>. <source/><italic>Mamm. Genome</italic>
<volume>25</volume>, <fpage>41</fpage>-<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1007/s00335-013-9487-6</pub-id><pub-id pub-id-type="pmid">24317506</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grove</surname><given-names>K. L.</given-names></name>, <name><surname>Grayson</surname><given-names>B. E.</given-names></name>, <name><surname>Glavas</surname><given-names>M. M.</given-names></name>, <name><surname>Xiao</surname><given-names>X. Q.</given-names></name> and <name><surname>Smith</surname><given-names>M. S.</given-names></name></person-group> (<year>2005</year>). <article-title>Development of metabolic systems</article-title>. <source/><italic>Physiol. Behav.</italic>
<volume>86</volume>, <fpage>646</fpage>-<lpage>660</lpage>. <pub-id pub-id-type="doi">10.1016/j.physbeh.2005.08.063</pub-id><pub-id pub-id-type="pmid">16289141</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halford</surname><given-names>J. C. G.</given-names></name> and <name><surname>Harrold</surname><given-names>J. A.</given-names></name></person-group> (<year>2012</year>). <article-title>5-HT(2C) receptor agonists and the control of appetite</article-title>. <source/><italic>Handb. Exp. Pharmacol.</italic>
<volume>209</volume>, <fpage>349</fpage>-<lpage>356</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-642-24716-3_16</pub-id><pub-id pub-id-type="pmid">22249823</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heisler</surname><given-names>L. K.</given-names></name> and <name><surname>Tecott</surname><given-names>L. H.</given-names></name></person-group> (<year>2000</year>). <article-title>A paradoxical locomotor response in serotonin 5-HT(2C) receptor mutant mice</article-title>. <source/><italic>J. Neurosci.</italic>
<volume>20</volume>, <fpage>RC71</fpage>.<pub-id pub-id-type="pmid">10751458</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heisler</surname><given-names>L. K.</given-names></name>, <name><surname>Cowley</surname><given-names>M. A.</given-names></name>, <name><surname>Tecott</surname><given-names>L. H.</given-names></name>, <name><surname>Fan</surname><given-names>W.</given-names></name>, <name><surname>Low</surname><given-names>M. J.</given-names></name>, <name><surname>Smart</surname><given-names>J. L.</given-names></name>, <name><surname>Rubinstein</surname><given-names>M.</given-names></name>, <name><surname>Tatro</surname><given-names>J. B.</given-names></name>, <name><surname>Marcus</surname><given-names>J. N.</given-names></name>, <name><surname>Holstege</surname><given-names>H.</given-names></name><etal>et al.</etal></person-group> (<year>2002</year>). <article-title>Activation of central melanocortin pathways by fenfluramine</article-title>. <source/><italic>Science</italic>
<volume>297</volume>, <fpage>609</fpage>-<lpage>611</lpage>. <pub-id pub-id-type="doi">10.1126/science.1072327</pub-id><pub-id pub-id-type="pmid">12142539</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heisler</surname><given-names>L. K.</given-names></name>, <name><surname>Zhou</surname><given-names>L.</given-names></name>, <name><surname>Bajwa</surname><given-names>P.</given-names></name>, <name><surname>Hsu</surname><given-names>J.</given-names></name> and <name><surname>Tecott</surname><given-names>L. H.</given-names></name></person-group> (<year>2007</year>). <article-title>Serotonin 5-HT(2C) receptors regulate anxiety-like behavior</article-title>. <source/><italic>Genes Brain Behav.</italic>
<volume>6</volume>, <fpage>491</fpage>-<lpage>496</lpage>. <pub-id pub-id-type="doi">10.1111/j.1601-183X.2007.00316.x</pub-id><pub-id pub-id-type="pmid">17451451</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernandez</surname><given-names>J. R.</given-names></name>, <name><surname>Manjarrez</surname><given-names>G. G.</given-names></name> and <name><surname>Chagoya</surname><given-names>G.</given-names></name></person-group> (<year>1989</year>). <article-title>Newborn humans and rats malnourished in utero: free plasma L-tryptophan, neutral amino acids and brain serotonin synthesis</article-title>. <source/><italic>Brain Res.</italic>
<volume>488</volume>, <fpage>1</fpage>-<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/0006-8993(89)90687-2</pub-id><pub-id pub-id-type="pmid">2743105</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernandez-Rodriguez</surname><given-names>J.</given-names></name>, <name><surname>Meneses</surname><given-names>L.</given-names></name>, <name><surname>Herrera</surname><given-names>R.</given-names></name> and <name><surname>Manjarrez</surname><given-names>G.</given-names></name></person-group> (<year>2009</year>). <article-title>Another abnormal trait in the serotonin metabolism path in intrauterine growth-restricted infants</article-title>. <source/><italic>Neonatology</italic>
<volume>95</volume>, <fpage>125</fpage>-<lpage>131</lpage>. <pub-id pub-id-type="doi">10.1159/000153096</pub-id><pub-id pub-id-type="pmid">18776726</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horvath</surname><given-names>T. L.</given-names></name> and <name><surname>Bruning</surname><given-names>J. C.</given-names></name></person-group> (<year>2006</year>). <article-title>Developmental programming of the hypothalamus: a matter of fat</article-title>. <source/><italic>Nat. Med.</italic>
<volume>12</volume>, <fpage>52</fpage>-<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1038/nm0106-52</pub-id><pub-id pub-id-type="pmid">16397567</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoyer</surname><given-names>D.</given-names></name>, <name><surname>Pazos</surname><given-names>A.</given-names></name>, <name><surname>Probst</surname><given-names>A.</given-names></name> and <name><surname>Palacios</surname><given-names>J. M.</given-names></name></person-group> (<year>1986</year>). <article-title>Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites</article-title>. <source/><italic>Brain Res.</italic>
<volume>376</volume>, <fpage>97</fpage>-<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1016/0006-8993(86)90903-0</pub-id><pub-id pub-id-type="pmid">2941113</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Y.</given-names></name>, <name><surname>Xu</surname><given-names>H.</given-names></name>, <name><surname>Li</surname><given-names>H.</given-names></name>, <name><surname>Yang</surname><given-names>H.</given-names></name>, <name><surname>Chen</surname><given-names>Y.</given-names></name> and <name><surname>Shi</surname><given-names>X.</given-names></name></person-group> (<year>2012</year>). <article-title>Pre-gestational stress reduces the ratio of 5-HIAA to 5-HT and the expression of 5-HT1A receptor and serotonin transporter in the brain of fetal rat</article-title>. <source/><italic>BMC Neurosci.</italic>
<volume>13</volume>, <fpage>22</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2202-13-22</pub-id><pub-id pub-id-type="pmid">22373128</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irizarry</surname><given-names>R. A.</given-names></name>, <name><surname>Bolstad</surname><given-names>B. M.</given-names></name>, <name><surname>Collin</surname><given-names>F.</given-names></name>, <name><surname>Cope</surname><given-names>L. M.</given-names></name>, <name><surname>Hobbs</surname><given-names>B.</given-names></name> and <name><surname>Speed</surname><given-names>T. P.</given-names></name></person-group> (<year>2003</year>). <article-title>Summaries of Affymetrix GeneChip probe level data</article-title>. <source/><italic>Nucleic Acids Res.</italic>
<volume>31</volume>, <fpage>e15</fpage>
<pub-id pub-id-type="doi">10.1093/nar/gng015</pub-id><pub-id pub-id-type="pmid">12582260</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jennings</surname><given-names>B. J.</given-names></name>, <name><surname>Ozanne</surname><given-names>S. E.</given-names></name>, <name><surname>Dorling</surname><given-names>M. W.</given-names></name> and <name><surname>Hales</surname><given-names>C. N.</given-names></name></person-group> (<year>1999</year>). <article-title>Early growth determines longevity in male rats and may be related to telomere shortening in the kidney</article-title>. <source/><italic>FEBS Lett.</italic>
<volume>448</volume>, <fpage>4</fpage>-<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/S0014-5793(99)00336-1</pub-id><pub-id pub-id-type="pmid">10217398</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalyanasundaram</surname><given-names>S.</given-names></name></person-group> (<year>1976</year>). <article-title>Effect of dietary protein and calorie deficiency on tryptophan levels in the developing rat brain</article-title>. <source/><italic>J. Neurochem.</italic>
<volume>27</volume>, <fpage>1245</fpage>-<lpage>1247</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.1976.tb00335.x</pub-id><pub-id pub-id-type="pmid">12170615</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katsidoni</surname><given-names>V.</given-names></name>, <name><surname>Apazoglou</surname><given-names>K.</given-names></name> and <name><surname>Panagis</surname><given-names>G.</given-names></name></person-group> (<year>2011</year>). <article-title>Role of serotonin 5-HT2A and 5-HT2C receptors on brain stimulation reward and the reward-facilitating effect of cocaine</article-title>. <source/><italic>Psychopharmacology</italic>
<volume>213</volume>, <fpage>337</fpage>-<lpage>354</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-010-1887-7</pub-id><pub-id pub-id-type="pmid">20577718</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knott</surname><given-names>P. J.</given-names></name> and <name><surname>Curzon</surname><given-names>G.</given-names></name></person-group> (<year>1972</year>). <article-title>Free tryptophan in plasma and brain tryptophan metabolism</article-title>. <source/><italic>Nature</italic>
<volume>239</volume>, <fpage>452</fpage>-<lpage>453</lpage>. <pub-id pub-id-type="doi">10.1038/239452a0</pub-id><pub-id pub-id-type="pmid">4562870</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>D. D.</given-names></name>, <name><surname>Przydzial</surname><given-names>M. J.</given-names></name>, <name><surname>Ridley</surname><given-names>S. H.</given-names></name>, <name><surname>Yeo</surname><given-names>G. S. H.</given-names></name>, <name><surname>Rochford</surname><given-names>J. J.</given-names></name>, <name><surname>O'Rahilly</surname><given-names>S.</given-names></name> and <name><surname>Heisler</surname><given-names>L. K.</given-names></name></person-group> (<year>2008</year>). <article-title>Serotonin 5-HT 2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors</article-title>. <source/><italic>Endocrinology</italic>
<volume>149</volume>, <fpage>1323</fpage>-<lpage>1328</lpage>. <pub-id pub-id-type="doi">10.1210/en.2007-1321</pub-id><pub-id pub-id-type="pmid">18039773</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>D. D.</given-names></name>, <name><surname>Garfield</surname><given-names>A. S.</given-names></name>, <name><surname>Marston</surname><given-names>O. J.</given-names></name>, <name><surname>Shaw</surname><given-names>J.</given-names></name> and <name><surname>Heisler</surname><given-names>L. K.</given-names></name></person-group> (<year>2010</year>). <article-title>Brain serotonin system in the coordination of food intake and body weight</article-title>. <source/><italic>Pharmacol. Biochem. Behav.</italic>
<volume>97</volume>, <fpage>84</fpage>-<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.pbb.2010.09.003</pub-id><pub-id pub-id-type="pmid">20837046</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyddon</surname><given-names>R.</given-names></name>, <name><surname>Dwork</surname><given-names>A. J.</given-names></name>, <name><surname>Keddache</surname><given-names>M.</given-names></name>, <name><surname>Siever</surname><given-names>L. J.</given-names></name> and <name><surname>Dracheva</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>Serotonin 2c receptor RNA editing in major depression and suicide</article-title>. <source/><italic>World J. Biol. Psychiatry</italic>
<volume>14</volume>, <fpage>590</fpage>-<lpage>601</lpage>. <pub-id pub-id-type="doi">10.3109/15622975.2011.630406</pub-id><pub-id pub-id-type="pmid">22404657</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madden</surname><given-names>A. M. K.</given-names></name> and <name><surname>Zup</surname><given-names>S. L.</given-names></name></person-group> (<year>2014</year>). <article-title>Effects of developmental hyperserotonemia on juvenile play behavior, oxytocin and serotonin receptor expression in the hypothalamus are age and sex dependent</article-title>. <source/><italic>Physiol. Behav.</italic>
<volume>128</volume>, <fpage>260</fpage>-<lpage>269</lpage>. <pub-id pub-id-type="doi">10.1016/j.physbeh.2014.01.036</pub-id><pub-id pub-id-type="pmid">24530263</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manjarrez</surname><given-names>G. G.</given-names></name>, <name><surname>Magdaleno</surname><given-names>V. M.</given-names></name>, <name><surname>Chagoya</surname><given-names>G.</given-names></name> and <name><surname>Hernández-R</surname><given-names>J.</given-names></name></person-group> (<year>1996</year>). <article-title>Nutritional recovery does not reverse the activation of brain serotonin synthesis in the ontogenetically malnourished rat</article-title>. <source/><italic>Int. J. Dev. Neurosci.</italic>
<volume>14</volume>, <fpage>641</fpage>-<lpage>648</lpage>. <pub-id pub-id-type="doi">10.1016/0736-5748(96)00028-7</pub-id><pub-id pub-id-type="pmid">8930695</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manjarrez</surname><given-names>G.</given-names></name>, <name><surname>Contreras</surname><given-names>J. L.</given-names></name>, <name><surname>Chagoya</surname><given-names>G.</given-names></name> and <name><surname>Hernández-R</surname><given-names>J.</given-names></name></person-group> (<year>1998</year>). <article-title>Free tryptophan as an indicator of brain serotonin synthesis in infants</article-title>. <source/><italic>Pediatr. Neurol.</italic>
<volume>18</volume>, <fpage>57</fpage>-<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/S0887-8994(97)00163-X</pub-id><pub-id pub-id-type="pmid">9492093</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marston</surname><given-names>O. J.</given-names></name>, <name><surname>Garfield</surname><given-names>A. S.</given-names></name> and <name><surname>Heisler</surname><given-names>L. K.</given-names></name></person-group> (<year>2011</year>). <article-title>Role of central serotonin and melanocortin systems in the control of energy balance</article-title>. <source/><italic>Eur. J. Pharmacol.</italic>
<volume>660</volume>, <fpage>70</fpage>-<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2010.12.024</pub-id><pub-id pub-id-type="pmid">21216242</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin-Gronert</surname><given-names>M. S.</given-names></name>, <name><surname>Tarry-Adkins</surname><given-names>J. L.</given-names></name>, <name><surname>Cripps</surname><given-names>R. L.</given-names></name>, <name><surname>Chen</surname><given-names>J.-H.</given-names></name> and <name><surname>Ozanne</surname><given-names>S. E.</given-names></name></person-group> (<year>2008</year>). <article-title>Maternal protein restriction leads to early life alterations in the expression of key molecules involved in the aging process in rat offspring</article-title>. <source/><italic>Am. J. Physiol. Regul. Integr. Comp. Physiol.</italic>
<volume>294</volume>, <fpage>R494</fpage>-<lpage>R500</lpage>. <pub-id pub-id-type="doi">10.1152/ajpregu.00530.2007</pub-id><pub-id pub-id-type="pmid">18094069</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLean</surname><given-names>T. H.</given-names></name>, <name><surname>Parrish</surname><given-names>J. C.</given-names></name>, <name><surname>Braden</surname><given-names>M. R.</given-names></name>, <name><surname>Marona-Lewicka</surname><given-names>D.</given-names></name>, <name><surname>Gallardo-Godoy</surname><given-names>A.</given-names></name> and <name><surname>Nichols</surname><given-names>D. E.</given-names></name></person-group> (<year>2006</year>). <article-title>1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT 2A receptor agonists</article-title>. <source/><italic>J. Med. Chem.</italic>
<volume>49</volume>, <fpage>5794</fpage>-<lpage>5803</lpage>. <pub-id pub-id-type="doi">10.1021/jm060656o</pub-id><pub-id pub-id-type="pmid">16970404</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mestre</surname><given-names>T. A.</given-names></name>, <name><surname>Zurowski</surname><given-names>M.</given-names></name> and <name><surname>Fox</surname><given-names>S. H.</given-names></name></person-group> (<year>2013</year>). <article-title>5-Hydroxytryptamine 2A receptor antagonists as potential treatment for psychiatric disorders</article-title>. <source/><italic>Expert Opin. Investig. Drugs</italic>
<volume>22</volume>, <fpage>411</fpage>-<lpage>421</lpage>. <pub-id pub-id-type="doi">10.1517/13543784.2013.769957</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreno</surname><given-names>J. L.</given-names></name>, <name><surname>Holloway</surname><given-names>T.</given-names></name>, <name><surname>Albizu</surname><given-names>L.</given-names></name>, <name><surname>Sealfon</surname><given-names>S. C.</given-names></name> and <name><surname>González-Maeso</surname><given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists</article-title>. <source/><italic>Neurosci. Lett.</italic>
<volume>493</volume>, <fpage>76</fpage>-<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2011.01.046</pub-id><pub-id pub-id-type="pmid">21276828</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>R. C. T.</given-names></name>, <name><surname>Guimarães</surname><given-names>R. B.</given-names></name>, <name><surname>Nascimento</surname><given-names>C. M. O.</given-names></name> and <name><surname>Ribeiro</surname><given-names>E. B.</given-names></name></person-group> (<year>1999</year>). <article-title>Lateral hypothalamic serotonergic responsiveness to food intake in rat obesity as measured by microdialysis</article-title>. <source/><italic>Can. J. Physiol. Pharmacol.</italic>
<volume>77</volume>, <fpage>286</fpage>-<lpage>292</lpage>. <pub-id pub-id-type="doi">10.1139/y99-024</pub-id><pub-id pub-id-type="pmid">10535677</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oberlander</surname><given-names>T. F.</given-names></name></person-group> (<year>2012</year>). <article-title>Fetal serotonin signaling: setting pathways for early childhood development and behavior</article-title>. <source/><italic>J. Adolesc. Health</italic>
<volume>51</volume>, <fpage>S9</fpage>-<lpage>S16</lpage>. <pub-id pub-id-type="doi">10.1016/j.jadohealth.2012.04.009</pub-id><pub-id pub-id-type="pmid">22794534</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oberlander</surname><given-names>T. F.</given-names></name>, <name><surname>Grunau</surname><given-names>R.</given-names></name>, <name><surname>Mayes</surname><given-names>L.</given-names></name>, <name><surname>Riggs</surname><given-names>W.</given-names></name>, <name><surname>Rurak</surname><given-names>D.</given-names></name>, <name><surname>Papsdorf</surname><given-names>M.</given-names></name>, <name><surname>Misri</surname><given-names>S.</given-names></name> and <name><surname>Weinberg</surname><given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>Hypothalamic-pituitary-adrenal (HPA) axis function in 3-month old infants with prenatal selective serotonin reuptake inhibitor (SSRI) antidepressant exposure</article-title>. <source/><italic>Early Hum. Dev.</italic>
<volume>84</volume>, <fpage>689</fpage>-<lpage>697</lpage>. <pub-id pub-id-type="doi">10.1016/j.earlhumdev.2008.06.008</pub-id><pub-id pub-id-type="pmid">18639992</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozanne</surname><given-names>S. E.</given-names></name>, <name><surname>Lewis</surname><given-names>R.</given-names></name>, <name><surname>Jennings</surname><given-names>B. J.</given-names></name> and <name><surname>Hales</surname><given-names>C. N.</given-names></name></person-group> (<year>2004</year>). <article-title>Early programming of weight gain in mice prevents the induction of obesity by a highly palatable diet</article-title>. <source/><italic>Clin. Sci.</italic>
<volume>106</volume>, <fpage>141</fpage>-<lpage>145</lpage>. <pub-id pub-id-type="doi">10.1042/CS20030278</pub-id><pub-id pub-id-type="pmid">14507258</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>S.</given-names></name>, <name><surname>Harrold</surname><given-names>J. A.</given-names></name>, <name><surname>Widdowson</surname><given-names>P. S.</given-names></name> and <name><surname>Williams</surname><given-names>G.</given-names></name></person-group> (<year>1999</year>). <article-title>Increased binding at 5-HT(1A), 5-HT(1B), and 5-HT(2A) receptors and 5-HT transporters in diet-induced obese rats</article-title>. <source/><italic>Brain Res.</italic>
<volume>847</volume>, <fpage>90</fpage>-<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-8993(99)02055-7</pub-id><pub-id pub-id-type="pmid">10564740</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C65">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Paxinos</surname><given-names>G.</given-names></name> and <name><surname>Watson</surname><given-names>C.</given-names></name></person-group> (<year>1998</year>). <source/><italic>The Rat Brain in Stereotaxic Coordinates</italic>. <publisher-loc>London</publisher-loc>: <publisher-name>Academic Press</publisher-name>.</mixed-citation>
</ref>
<ref id="DMM023903C66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez-Cruet</surname><given-names>J.</given-names></name>, <name><surname>Tagliamonte</surname><given-names>A.</given-names></name>, <name><surname>Tagliamonte</surname><given-names>P.</given-names></name> and <name><surname>Gessa</surname><given-names>G. L.</given-names></name></person-group> (<year>1972</year>). <article-title>Changes in brain serotonin metabolism associated with fasting and satiation in rats</article-title>. <source/><italic>Life Sci.</italic>
<volume>11</volume>, <fpage>31</fpage>-<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1016/0024-3205(72)90149-X</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pino</surname><given-names>G. D.</given-names></name>, <name><surname>Moessner</surname><given-names>R.</given-names></name>, <name><surname>Lesch</surname><given-names>K. P.</given-names></name>, <name><surname>Lauder</surname><given-names>J. M.</given-names></name> and <name><surname>Persico</surname><given-names>A. M.</given-names></name></person-group> (<year>2004</year>). <article-title>Roles for serotonin in neurodevelopment: more than just neural transmission</article-title>. <source/><italic>Curr. Neuropharmacol.</italic>
<volume>2</volume>, <fpage>403</fpage>-<lpage>417</lpage>. <pub-id pub-id-type="doi">10.2174/1570159043359495</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plagemann</surname><given-names>A.</given-names></name>, <name><surname>Heidrich</surname><given-names>I.</given-names></name>, <name><surname>Götz</surname><given-names>F.</given-names></name>, <name><surname>Rohde</surname><given-names>W.</given-names></name> and <name><surname>Dörner</surname><given-names>G.</given-names></name></person-group> (<year>1992</year>). <article-title>Obesity and enhanced diabetes and cardiovascular risk in adult rats due to early postnatal overfeeding</article-title>. <source/><italic>Exp. Clin. Endocrinol.</italic>
<volume>99</volume>, <fpage>154</fpage>-<lpage>158</lpage>. <pub-id pub-id-type="doi">10.1055/s-0029-1211159</pub-id><pub-id pub-id-type="pmid">1526266</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pôrto</surname><given-names>L. C. J.</given-names></name>, <name><surname>Sardinha</surname><given-names>F. L. C.</given-names></name>, <name><surname>Telles</surname><given-names>M. M.</given-names></name>, <name><surname>Guimarães</surname><given-names>R. B.</given-names></name>, <name><surname>Albuquerque</surname><given-names>K. T.</given-names></name>, <name><surname>Andrade</surname><given-names>I. S.</given-names></name>, <name><surname>Oyama</surname><given-names>L. M.</given-names></name>, <name><surname>Nascimento</surname><given-names>C. M. O.</given-names></name>, <name><surname>Santos</surname><given-names>O. F. P.</given-names></name> and <name><surname>Ribeiro</surname><given-names>E. B.</given-names></name></person-group> (<year>2009</year>). <article-title>Impairment of the serotonergic control of feeding in adult female rats exposed to intra-uterine malnutrition</article-title>. <source/><italic>Br. J. Nutr.</italic>
<volume>101</volume>, <fpage>1255</fpage>-<lpage>1261</lpage>. <pub-id pub-id-type="doi">10.1017/S0007114508061503</pub-id><pub-id pub-id-type="pmid">18786279</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C70">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ramachandra</surname><given-names>R.</given-names></name> and <name><surname>Subramanian</surname><given-names>T.</given-names></name></person-group> (<year>2011</year>). <source/><italic>Neonatal Rat Brain</italic>. <publisher-loc>London</publisher-loc>: <publisher-name>CRC Press</publisher-name>.</mixed-citation>
</ref>
<ref id="DMM023903C71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ravelli</surname><given-names>G.-P.</given-names></name>, <name><surname>Stein</surname><given-names>Z. A.</given-names></name> and <name><surname>Susser</surname><given-names>M. W.</given-names></name></person-group> (<year>1976</year>). <article-title>Obesity in young men after famine exposure in utero and early infancy</article-title>. <source/><italic>N. Engl. J. Med.</italic>
<volume>295</volume>, <fpage>349</fpage>-<lpage>353</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM197608122950701</pub-id><pub-id pub-id-type="pmid">934222</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosmond</surname><given-names>R.</given-names></name>, <name><surname>Bouchard</surname><given-names>C.</given-names></name> and <name><surname>Björntorp</surname><given-names>P.</given-names></name></person-group> (<year>2002</year>). <article-title>5-HT 2A receptor gene promoter polymorphism in relation to abdominal obesity and cortisol</article-title>. <source/><italic>Obes. Res.</italic>
<volume>10</volume>, <fpage>585</fpage>-<lpage>589</lpage>. <pub-id pub-id-type="doi">10.1038/oby.2002.79</pub-id><pub-id pub-id-type="pmid">12105278</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roux</surname><given-names>J. M.</given-names></name> and <name><surname>Jahchan</surname><given-names>T.</given-names></name></person-group> (<year>1974</year>). <article-title>Plasma level of amino-acids in the developing young rat after intra-uterine growth retardation</article-title>. <source/><italic>Life. Sci.</italic>
<volume>14</volume>, <fpage>1101</fpage>-<lpage>1107</lpage>. <pub-id pub-id-type="doi">10.1016/0024-3205(74)90234-3</pub-id><pub-id pub-id-type="pmid">4822919</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruggiero</surname><given-names>T.</given-names></name>, <name><surname>Trabucchi</surname><given-names>M.</given-names></name>, <name><surname>Ponassi</surname><given-names>M.</given-names></name>, <name><surname>Corte</surname><given-names>G.</given-names></name>, <name><surname>Chen</surname><given-names>C.-Y.</given-names></name>, <name><surname>al-Haj</surname><given-names>L.</given-names></name>, <name><surname>Khabar</surname><given-names>K. S. A.</given-names></name>, <name><surname>Briata</surname><given-names>P.</given-names></name> and <name><surname>Gherzi</surname><given-names>R.</given-names></name></person-group> (<year>2007</year>). <article-title>Identification of a set of KSRP target transcripts upregulated by PI3K-AKT signaling</article-title>. <source/><italic>BMC Mol. Biol.</italic>
<volume>8</volume>, <fpage>28</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2199-8-28</pub-id><pub-id pub-id-type="pmid">17437629</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>K. P.</given-names></name>, <name><surname>Gratz</surname><given-names>S. W.</given-names></name>, <name><surname>Sheridan</surname><given-names>P. O.</given-names></name>, <name><surname>Flint</surname><given-names>H. J.</given-names></name> and <name><surname>Duncan</surname><given-names>S. H.</given-names></name></person-group> (<year>2013</year>). <article-title>The influence of diet on the gut microbiota</article-title>. <source/><italic>Pharmacol. Res.</italic>
<volume>69</volume>, <fpage>52</fpage>-<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2012.10.020</pub-id><pub-id pub-id-type="pmid">23147033</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singhal</surname><given-names>A.</given-names></name>, <name><surname>Kennedy</surname><given-names>K.</given-names></name>, <name><surname>Lanigan</surname><given-names>J.</given-names></name>, <name><surname>Fewtrell</surname><given-names>M.</given-names></name>, <name><surname>Cole</surname><given-names>T. J.</given-names></name>, <name><surname>Stephenson</surname><given-names>T.</given-names></name>, <name><surname>Elias-Jones</surname><given-names>A.</given-names></name>, <name><surname>Weaver</surname><given-names>L. T.</given-names></name>, <name><surname>Ibhanesebhor</surname><given-names>S.</given-names></name>, <name><surname>MacDonald</surname><given-names>P. D.</given-names></name><etal>et al.</etal></person-group> (<year>2010</year>). <article-title>Nutrition in infancy and long-term risk of obesity: evidence from 2 randomized controlled trials</article-title>. <source/><italic>Am. J. Clin. Nutr.</italic>
<volume>92</volume>, <fpage>1133</fpage>-<lpage>1144</lpage>. <pub-id pub-id-type="doi">10.3945/ajcn.2010.29302</pub-id><pub-id pub-id-type="pmid">20881062</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steculorum</surname><given-names>S. M.</given-names></name> and <name><surname>Bouret</surname><given-names>S. G.</given-names></name></person-group> (<year>2011</year>). <article-title>Maternal diabetes compromises the organization of hypothalamic feeding circuits and impairs leptin sensitivity in offspring</article-title>. <source/><italic>Endocrinology</italic>
<volume>152</volume>, <fpage>4171</fpage>-<lpage>4179</lpage>. <pub-id pub-id-type="doi">10.1210/en.2011-1279</pub-id><pub-id pub-id-type="pmid">21862611</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stocker</surname><given-names>C. J.</given-names></name>, <name><surname>Wargent</surname><given-names>E. T.</given-names></name>, <name><surname>Martin-Gronert</surname><given-names>M. S.</given-names></name>, <name><surname>Cripps</surname><given-names>R. L.</given-names></name>, <name><surname>O'Dowd</surname><given-names>J. F.</given-names></name>, <name><surname>Zaibi</surname><given-names>M. S.</given-names></name>, <name><surname>Cottrell</surname><given-names>E. C.</given-names></name>, <name><surname>Mercer</surname><given-names>J. G.</given-names></name>, <name><surname>Duncan</surname><given-names>J. S.</given-names></name>, <name><surname>Cawthorne</surname><given-names>M. A.</given-names></name><etal>et al.</etal></person-group> (<year>2012</year>). <article-title>Leanness in postnatally nutritionally programmed rats is associated with increased sensitivity to leptin and a melanocortin receptor agonist and decreased sensitivity to neuropeptide Y</article-title>. <source/><italic>Int. J. Obes.</italic>
<volume>36</volume>, <fpage>1040</fpage>-<lpage>1046</lpage>. <pub-id pub-id-type="doi">10.1038/ijo.2011.226</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>E. L.</given-names></name>, <name><surname>Grayson</surname><given-names>B.</given-names></name>, <name><surname>Takahashi</surname><given-names>D.</given-names></name>, <name><surname>Robertson</surname><given-names>N.</given-names></name>, <name><surname>Maier</surname><given-names>A.</given-names></name>, <name><surname>Bethea</surname><given-names>C. L.</given-names></name>, <name><surname>Smith</surname><given-names>M. S.</given-names></name>, <name><surname>Coleman</surname><given-names>K.</given-names></name> and <name><surname>Grove</surname><given-names>K. L.</given-names></name></person-group> (<year>2010</year>). <article-title>Chronic consumption of a high-fat diet during pregnancy causes perturbations in the serotonergic system and increased anxiety-like behavior in nonhuman primate offspring</article-title>. <source/><italic>J. Neurosci.</italic>
<volume>30</volume>, <fpage>3826</fpage>-<lpage>3830</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5560-09.2010</pub-id><pub-id pub-id-type="pmid">20220017</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarry-Adkins</surname><given-names>J. L.</given-names></name>, <name><surname>Martin-Gronert</surname><given-names>M. S.</given-names></name>, <name><surname>Chen</surname><given-names>J.-H.</given-names></name>, <name><surname>Cripps</surname><given-names>R. L.</given-names></name> and <name><surname>Ozanne</surname><given-names>S. E.</given-names></name></person-group> (<year>2008</year>). <article-title>Maternal diet influences DNA damage, aortic telomere length, oxidative stress, and antioxidant defense capacity in rats</article-title>. <source/><italic>FASEB J.</italic>
<volume>22</volume>, <fpage>2037</fpage>-<lpage>2044</lpage>. <pub-id pub-id-type="doi">10.1096/fj.07-099523</pub-id><pub-id pub-id-type="pmid">18230683</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarry-Adkins</surname><given-names>J. L.</given-names></name>, <name><surname>Chen</surname><given-names>J. H.</given-names></name>, <name><surname>Smith</surname><given-names>N. S.</given-names></name>, <name><surname>Jones</surname><given-names>R. H.</given-names></name>, <name><surname>Cherif</surname><given-names>H.</given-names></name> and <name><surname>Ozanne</surname><given-names>S. E.</given-names></name></person-group> (<year>2009</year>). <article-title>Poor maternal nutrition followed by accelerated postnatal growth leads to telomere shortening and increased markers of cell senescence in rat islets</article-title>. <source/><italic>FASEB J.</italic>
<volume>23</volume>, <fpage>1521</fpage>-<lpage>1528</lpage>. <pub-id pub-id-type="doi">10.1096/fj.08-122796</pub-id><pub-id pub-id-type="pmid">19126595</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tecott</surname><given-names>L. H.</given-names></name>, <name><surname>Sun</surname><given-names>L. M.</given-names></name>, <name><surname>Akana</surname><given-names>S. F.</given-names></name>, <name><surname>Strack</surname><given-names>A. M.</given-names></name>, <name><surname>Lowenstein</surname><given-names>D. H.</given-names></name>, <name><surname>Dallman</surname><given-names>M. F.</given-names></name> and <name><surname>Julius</surname><given-names>D.</given-names></name></person-group> (<year>1995</year>). <article-title>Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors</article-title>. <source/><italic>Nature</italic>
<volume>374</volume>, <fpage>542</fpage>-<lpage>546</lpage>. <pub-id pub-id-type="doi">10.1038/374542a0</pub-id><pub-id pub-id-type="pmid">7700379</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trabucchi</surname><given-names>M.</given-names></name>, <name><surname>Briata</surname><given-names>P.</given-names></name>, <name><surname>Garcia-Mayoral</surname><given-names>M.</given-names></name>, <name><surname>Haase</surname><given-names>A. D.</given-names></name>, <name><surname>Filipowicz</surname><given-names>W.</given-names></name>, <name><surname>Ramos</surname><given-names>A.</given-names></name>, <name><surname>Gherzi</surname><given-names>R.</given-names></name> and <name><surname>Rosenfeld</surname><given-names>M. G.</given-names></name></person-group> (<year>2009</year>). <article-title>The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs</article-title>. <source/><italic>Nature</italic>
<volume>459</volume>, <fpage>1010</fpage>-<lpage>1014</lpage>. <pub-id pub-id-type="doi">10.1038/nature08025</pub-id><pub-id pub-id-type="pmid">19458619</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trifunovic</surname><given-names>R.</given-names></name> and <name><surname>Reilly</surname><given-names>S.</given-names></name></person-group> (<year>2006</year>). <article-title>Medial parabrachial nucleus neurons modulate d-fenfluramine-induced anorexia through 5HT2C receptors</article-title>. <source/><italic>Brain Res.</italic>
<volume>1067</volume>, <fpage>170</fpage>-<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2005.10.092</pub-id><pub-id pub-id-type="pmid">16343451</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vickers</surname><given-names>S. P.</given-names></name>, <name><surname>Clifton</surname><given-names>P. G.</given-names></name>, <name><surname>Dourish</surname><given-names>C. T.</given-names></name> and <name><surname>Tecott</surname><given-names>L. H.</given-names></name></person-group> (<year>1999</year>). <article-title>Reduced satiating effect of d-fenfluramine in serotonin 5-HT(2C) receptor mutant mice</article-title>. <source/><italic>Psychopharmacology</italic>
<volume>143</volume>, <fpage>309</fpage>-<lpage>314</lpage>. <pub-id pub-id-type="doi">10.1007/s002130050952</pub-id><pub-id pub-id-type="pmid">10353435</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vickers</surname><given-names>S. P.</given-names></name>, <name><surname>Dourish</surname><given-names>C. T.</given-names></name> and <name><surname>Kennett</surname><given-names>G. A.</given-names></name></person-group> (<year>2001</year>). <article-title>Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors</article-title>. <source/><italic>Neuropharmacology</italic>
<volume>41</volume>, <fpage>200</fpage>-<lpage>209</lpage>. <pub-id pub-id-type="doi">10.1016/S0028-3908(01)00063-6</pub-id><pub-id pub-id-type="pmid">11489456</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weisstaub</surname><given-names>N. V.</given-names></name>, <name><surname>Zhou</surname><given-names>M.</given-names></name>, <name><surname>Lira</surname><given-names>A.</given-names></name>, <name><surname>Lambe</surname><given-names>E.</given-names></name>, <name><surname>González-Maeso</surname><given-names>J.</given-names></name>, <name><surname>Hornung</surname><given-names>J.-P.</given-names></name>, <name><surname>Sibille</surname><given-names>E.</given-names></name>, <name><surname>Underwood</surname><given-names>M.</given-names></name>, <name><surname>Itohara</surname><given-names>S.</given-names></name>, <name><surname>Dauer</surname><given-names>W. T.</given-names></name><etal>et al.</etal></person-group> (<year>2006</year>). <article-title>Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice</article-title>. <source/><italic>Science</italic>
<volume>313</volume>, <fpage>536</fpage>-<lpage>540</lpage>. <pub-id pub-id-type="doi">10.1126/science.1123432</pub-id><pub-id pub-id-type="pmid">16873667</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitaker-Azmitia</surname><given-names>P. M.</given-names></name>, <name><surname>Druse</surname><given-names>M.</given-names></name>, <name><surname>Walker</surname><given-names>P.</given-names></name> and <name><surname>Lauder</surname><given-names>J. M.</given-names></name></person-group> (<year>1996</year>). <article-title>Serotonin as a developmental signal</article-title>. <source/><italic>Behav. Brain Res.</italic>
<volume>73</volume>, <fpage>193ai</fpage>.<pub-id pub-id-type="pmid">8788501</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Z.</given-names></name>, <name><surname>Irizarry</surname><given-names>R. A.</given-names></name>, <name><surname>Gentleman</surname><given-names>R.</given-names></name>, <name><surname>Martinez-Murillo</surname><given-names>F.</given-names></name> and <name><surname>Spencer</surname><given-names>F.</given-names></name></person-group> (<year>2004</year>). <article-title>A model-based background adjustment for oligonucleotide expression arrays</article-title>. <source/><italic>J. Am. Stat. Assoc.</italic>
<volume>99</volume>, <fpage>909</fpage>-<lpage>917</lpage>. <pub-id pub-id-type="doi">10.1198/016214504000000683</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y.</given-names></name>, <name><surname>Jones</surname><given-names>J. E.</given-names></name>, <name><surname>Kohno</surname><given-names>D.</given-names></name>, <name><surname>Williams</surname><given-names>K. W.</given-names></name>, <name><surname>Lee</surname><given-names>C. E.</given-names></name>, <name><surname>Choi</surname><given-names>M. J.</given-names></name>, <name><surname>Anderson</surname><given-names>J. G.</given-names></name>, <name><surname>Heisler</surname><given-names>L. K.</given-names></name>, <name><surname>Zigman</surname><given-names>J. M.</given-names></name>, <name><surname>Lowell</surname><given-names>B. B.</given-names></name><etal>et al.</etal></person-group> (<year>2008</year>). <article-title>5-HT2CRs expressed by pro-opiomelanocortin neurons regulate energy homeostasis</article-title>. <source/><italic>Neuron</italic>
<volume>60</volume>, <fpage>582</fpage>-<lpage>589</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2008.09.033</pub-id><pub-id pub-id-type="pmid">19038216</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y.</given-names></name>, <name><surname>Jones</surname><given-names>J. E.</given-names></name>, <name><surname>Lauzon</surname><given-names>D. A.</given-names></name>, <name><surname>Anderson</surname><given-names>J. G.</given-names></name>, <name><surname>Balthasar</surname><given-names>N.</given-names></name>, <name><surname>Heisler</surname><given-names>L. K.</given-names></name>, <name><surname>Zinn</surname><given-names>A. R.</given-names></name>, <name><surname>Lowel</surname><given-names>B. B.</given-names></name> and <name><surname>Elmquist</surname><given-names>J. K.</given-names></name></person-group> (<year>2010</year>). <article-title>A serotonin and melanocortin circuit mediates D-fenfluramine anorexia</article-title>. <source/><italic>J. Neurosci.</italic>
<volume>30</volume>, <fpage>14630</fpage>-<lpage>14634</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5412-09.2010</pub-id><pub-id pub-id-type="pmid">21048120</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yano</surname><given-names>J. M.</given-names></name>, <name><surname>Yu</surname><given-names>K.</given-names></name>, <name><surname>Donaldson</surname><given-names>G. P.</given-names></name>, <name><surname>Shastri</surname><given-names>G. G.</given-names></name>, <name><surname>Ann</surname><given-names>P.</given-names></name>, <name><surname>Ma</surname><given-names>L.</given-names></name>, <name><surname>Nagler</surname><given-names>C. R.</given-names></name>, <name><surname>Ismagilov</surname><given-names>R. F.</given-names></name>, <name><surname>Mazmanian</surname><given-names>S. K.</given-names></name> and <name><surname>Hsiao</surname><given-names>E. Y.</given-names></name></person-group> (<year>2015</year>). <article-title>Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis</article-title>. <source/><italic>Cell</italic>
<volume>161</volume>, <fpage>264</fpage>-<lpage>276</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2015.02.047</pub-id><pub-id pub-id-type="pmid">25860609</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yura</surname><given-names>S.</given-names></name>, <name><surname>Itoh</surname><given-names>H.</given-names></name>, <name><surname>Sagawa</surname><given-names>N.</given-names></name>, <name><surname>Yamamoto</surname><given-names>H.</given-names></name>, <name><surname>Masuzaki</surname><given-names>H.</given-names></name>, <name><surname>Nakao</surname><given-names>K.</given-names></name>, <name><surname>Kawamura</surname><given-names>M.</given-names></name>, <name><surname>Takemura</surname><given-names>M.</given-names></name>, <name><surname>Kakui</surname><given-names>K.</given-names></name>, <name><surname>Ogawa</surname><given-names>Y.</given-names></name><etal>et al.</etal></person-group> (<year>2005</year>). <article-title>Role of premature leptin surge in obesity resulting from intrauterine undernutrition</article-title>. <source/><italic>Cell Metab.</italic>
<volume>1</volume>, <fpage>371</fpage>-<lpage>378</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2005.05.005</pub-id><pub-id pub-id-type="pmid">16054086</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaibi</surname><given-names>M. S.</given-names></name>, <name><surname>Stocker</surname><given-names>C. J.</given-names></name>, <name><surname>O'Dowd</surname><given-names>J.</given-names></name>, <name><surname>Davies</surname><given-names>A.</given-names></name>, <name><surname>Bellahcene</surname><given-names>M.</given-names></name>, <name><surname>Cawthorne</surname><given-names>M. A.</given-names></name>, <name><surname>Brown</surname><given-names>A. J. H.</given-names></name>, <name><surname>Smith</surname><given-names>D. M.</given-names></name> and <name><surname>Arch</surname><given-names>J. R. S.</given-names></name></person-group> (<year>2010</year>). <article-title>Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids</article-title>. <source/><italic>FEBS Lett.</italic>
<volume>584</volume>, <fpage>2381</fpage>-<lpage>2386</lpage>. <pub-id pub-id-type="doi">10.1016/j.febslet.2010.04.027</pub-id><pub-id pub-id-type="pmid">20399779</pub-id></mixed-citation>
</ref>
<ref id="DMM023903C96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X.</given-names></name>, <name><surname>Wan</surname><given-names>G.</given-names></name>, <name><surname>Berger</surname><given-names>F. G.</given-names></name>, <name><surname>He</surname><given-names>X.</given-names></name> and <name><surname>Lu</surname><given-names>X.</given-names></name></person-group> (<year>2011</year>). <article-title>The ATM kinase induces microRNA biogenesis in the DNA damage response</article-title>. <source/><italic>Mol. Cell</italic>
<volume>41</volume>, <fpage>371</fpage>-<lpage>383</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2011.01.020</pub-id><pub-id pub-id-type="pmid">21329876</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>